Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 31645-39-3 Chemical Structure| 31645-39-3
Chemical Structure| 31645-39-3

*Storage: Keep in dark place, inert atmosphere, store in freezer, under -20°C.

Palifosfamide

CAS No.: 31645-39-3

Palifosfamide is the functional active metabolite of ifosfamide (IFOS), a bi-functional DNA alkylator being investigated as a potential therapy for the treatment of soft tissue sarcoma (STS).

Synonyms: Isophosphoramide mustard; ZIO-201; NSC 297900

4.5 *For Research Use Only !

Cat. No.: A498867 Purity: 98+%

Change View

Size Price

US Stock

Global Stock

In Stock
1mg łÍÿ¶ÊÊ Inquiry In Stock Login
2mg łÿď¶ÊÊ Inquiry In Stock Login
5mg łďͶÊÊ In Stock In Stock Login
10mg łîÿ¶ÊÊ In Stock In Stock Login
25mg łÇË˶ÊÊ Inquiry In Stock Login
50mg łËÊď¶ÊÊ In Stock In Stock Login
100mg ł§ÿʶÊÊ In Stock In Stock Login
250mg łòòÿ¶ÊÊ In Stock In Stock Login

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1mg

    łÍÿ¶ÊÊ

  • 2mg

    łÿď¶ÊÊ

  • 5mg

    łďͶÊÊ

  • 10mg

    łîÿ¶ÊÊ

  • 25mg

    łÇË˶ÊÊ

  • 50mg

    łËÊď¶ÊÊ

  • 100mg

    ł§ÿʶÊÊ

  • 250mg

    łòòÿ¶ÊÊ

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support Online Technical Q&A
Product Citations

Alternative Products

Product Details of Palifosfamide

CAS No. :31645-39-3
Formula : C4H11Cl2N2O2P
M.W : 221.02
SMILES Code : O=P(NCCCl)(NCCCl)O
Synonyms :
Isophosphoramide mustard; ZIO-201; NSC 297900
MDL No. :MFCD01705455

Safety of Palifosfamide

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H301-H311-H314-H331
Precautionary Statements:P260-P264-P270-P271-P280-P301+P330+P331-P302+P352-P303+P361+P353-P304+P340-P305+P351+P338-P310-P403+P233-P405-P501
Class:8(6.1)
UN#:2923
Packing Group:

Related Pathways of Palifosfamide

DNA

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02219737 CD20 Positive ... More >> Recurrent Diffuse Large B-Cell Lymphoma Refractory Diffuse Large B-Cell Lymphoma Less << Phase 1 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT02441309 Osteosarcoma Phase 2 Completed - Germany ... More >> Pediatric Hematology and Oncology, University Hospital Münster Münster, Germany, 48149 Italy Istituti Ortopedici Rizzoli Bologna, Emilia-Romagna, Italy, 40136 Netherlands Department of Clinical Oncology, Leiden University Medical Center Leiden, Postzone K1-P, Netherlands, P.O. Box 9600 Norway Radium Hospital, Oslo University Oslo, Norway, 0310 United Kingdom Leeds Teaching Hospitals NHS Trust Leeds, United Kingdom, LS9 7TF University College London Hospitals NHS Foundation Trust London, United Kingdom, NW1 2BU Christie Hospital NHS Foundation Trust Manchester, United Kingdom, M20 4BX Oxford University Hospitals NHS Foundations Trust Oxford, United Kingdom, OX3 7LE Less <<
NCT00145639 Osteosarcoma Phase 2 Completed - United States, Arkansas ... More >> Arkansas Children's Hospital Little Rock, Arkansas, United States, 72202 United States, Missouri Washington University Medical Center St.Louis, Missouri, United States, 63110 United States, Tennessee St.Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Chile Hospital Luis Calvo Mackenna Santiago, Chile Less <<
NCT00512096 - Completed - -
NCT00512096 Penile Cancer Phase 2 Completed - United States, Texas ... More >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01169636 Hodgkin's Lymphoma Phase 1 Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01966913 Germ Cell Tumor Phase 1 Phase 2 Recruiting September 2018 France ... More >> Hopital Tenon Recruiting Paris, France, 75012 Less <<
NCT00204646 Sarcoma, Soft Tissue Phase 2 Completed - Germany ... More >> Medical Center II, University of Tuebingen Tuebingen, Germany, 72076 Less <<
NCT03349346 Diffuse Large B-Cell Lymphoma ... More >> Mediastinal B-cell Lymphoma Less << Phase 1 Withdrawn(The European Medical... More >> Agency granted a Paediatric Investigational Product-specific waiver on the grounds that idelalisib is likely to be unsafe in paediatrics) Less << February 2026 France ... More >> Centre Hospitalier Régional Universitaire de Lille Lille, France, 59000 Italy Istituto Giannina Gaslini Genova, Italy, 16147 Ospedale Pediatrico Bambino Gesu Roma, Italy, 00165 Infantile Regina Margherita Hospital Torino, Italy, 10126 Poland Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wroclawiu Wrocław, Poland, 50-556 Spain Hospital Vall d´Hebrón Barcelona, Spain, 08035 Hospital Universitario HM Monteprincipe Madrid, Spain, 28660 Less <<
NCT00967369 Hodgkin's Lymphoma Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02592876 Lymphoma, B-cell ... More >> Lymphoma, Large B-Cell, Diffuse Lymphoma, Follicular, Grade 3b Follicular Lymphoma, Grade 3b Less << Phase 2 Terminated(Sponsor decision ba... More >>sed on portfolio prioritization) Less << - -
NCT00003657 Bladder Cancer ... More >> Brain and Central Nervous System Tumors Carcinoma of Unknown Primary Extragonadal Germ Cell Tumor Head and Neck Cancer Kidney Cancer Lung Cancer Ovarian Cancer Sarcoma Testicular Germ Cell Tumor Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT00101205 Angioimmunoblastic T-cell Lymp... More >>homa B-cell Childhood Acute Lymphoblastic Leukemia B-cell Chronic Lymphocytic Leukemia Childhood Burkitt Lymphoma Childhood Diffuse Large Cell Lymphoma Childhood Grade III Lymphomatoid Granulomatosis Childhood Immunoblastic Large Cell Lymphoma Childhood Nasal Type Extranodal NK/T-cell Lymphoma Hepatosplenic T-cell Lymphoma Intraocular Lymphoma Noncutaneous Extranodal Lymphoma Peripheral T-cell Lymphoma Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Anaplastic Large Cell Lymphoma Recurrent Childhood Grade III Lymphomatoid Granulomatosis Recurrent Childhood Large Cell Lymphoma Recurrent Childhood Lymphoblastic Lymphoma Recurrent Childhood Small Noncleaved Cell Lymphoma Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent/Refractory Childhood Hodgkin Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Hairy Cell Leukemia Small Intestine Lymphoma T-cell Childhood Acute Lymphoblastic Leukemia T-cell Large Granular Lymphocyte Leukemia Unspecified Childhood Solid Tumor, Protocol Specific Less << Phase 1 Terminated - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00598169 Lymphoma Phase 1 Completed - United States, California ... More >> Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States, 92093-0658 USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States, 90089-9181 UCLA Clinical AIDS Research and Education (CARE) Center Los Angeles, California, United States, 90095-1793 University of California at Davis Center for Aids Research and Education Services Sacramento, California, United States, 95814 United States, Florida University of Miami Sylvester Comprehensive Cancer Center - Miami Miami, Florida, United States, 33136 United States, Georgia Emory Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Hawaii Cancer Research Center of Hawaii Honolulu, Hawaii, United States, 96813 United States, Illinois Northwestern Cancer Center Chicago, Illinois, United States, 60611 United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 United States, New York Montefiore Medical Center Bronx, New York, United States, 10467-2490 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 United States, Ohio Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210-1240 United States, Pennsylvania Pennsylvania Oncology Hematology Associates, Incorporated - Philadelphia Philadelphia, Pennsylvania, United States, 19106 United States, Texas Thomas Street Health Center Houston, Texas, United States, 77009 Baylor College of Medicine Houston, Texas, United States, 77030-2707 United States, Washington Virginia Mason Medical Center Seattle, Washington, United States, 98101 Less <<
NCT00004186 Lung Cancer Phase 1 Phase 2 Completed - United States, Alabama ... More >> University of Alabama Comprehensive Cancer Center Birmingham, Alabama, United States, 35294 Less <<
NCT03121833 Soft Tissue Sarcoma, Adult, St... More >>age IIB Less << Phase 2 Recruiting May 1, 2019 China, Tianjin ... More >> Tianjin Medical University Cancer Hospital & Institute Recruiting Tianjin, Tianjin, China, 300060 Contact: Jilong Yang, M.D., Ph.D.    +8618622221626    yangjilong@tjmuch.com Less <<
NCT00965172 Sarcoma Oral ... More >>Mucositis Less << Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01501136 Nasal and Nasal-type NK/T-cell... More >> Lymphoma Less << Phase 4 Recruiting May 2019 China, Henan ... More >> Oncology Department of The First Affiliated Hospital of Zhengzhou University Recruiting Zhengzhou, Henan, China, 450052 Contact: Mingzhi Zhang, Pro,Dr    13838565629    mingzhi_zhang@126.com    Principal Investigator: Mingzhi Zhang, Pro,Dr Less <<
NCT00104676 Extragonadal Germ Cell Tumor ... More >> Teratoma Testicular Germ Cell Tumor Less << Phase 3 Unknown - United States, Texas ... More >> M. D. Anderson Cancer Center at University of Texas Recruiting Houston, Texas, United States, 77030-4009 Contact: Clinical Trials Office - M. D. Anderson Cancer Center at the U    713-792-3245       France Centre Paul Papin Recruiting Angers, France, 49100 Contact: Remy Delva    33-49-800-918-507       Institut Bergonie Recruiting Bordeaux, France, 33076 Contact: Nguyen Binh Bui, MD    33-5-5633-3813       C.H.U. de Brest Recruiting Brest, France, 29609 Contact: Jean-Pierre Malhaire, MD    33-298-223-333 ext. 233-95       Centre Regional Francois Baclesse Recruiting Caen, France, 14076 Contact: Emmanuel Sevin, MD    33-2-3145-5000    e.sevin@baclesse.fr    CHU de Grenoble - Hopital de la Tronche Recruiting Grenoble, France, 38043 Contact: Francois Ringeisen    33-4-7676-5537       Centre Oscar Lambret Recruiting Lille, France, 59020 Contact: Armelle Caty, MD    33-32-029-5959    acaty@o-lambret.fr    Centre Leon Berard Recruiting Lyon, France, 69008 Contact: Aude Flechon    33-4-78-78-26-45       Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes Recruiting Marseille, France, 13273 Contact: Gwenaelle Gravis, MD    33-4-9122-3740    gravisg@marseille.fnclcc.fr    Hopital Notre-Dame de Bon Secours Recruiting Metz, France, 57038 Contact: Christian Platini, MD    33-3-8755-3554    cplatini@chr-metz-thionville.fr    Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle Recruiting Montpellier, France, 34298 Contact: Stephane Culine, MD    33-4-6761-3755    stculine@valdorel.fnclcc.fr    CRLCC Nantes - Atlantique Recruiting Nantes-Saint Herblain, France, 44805 Contact: Frederic Rolland, MD    33-2-40-67-99-76    F-rolland@nantes.fnclcc.fr    Centre Antoine Lacassagne Recruiting Nice, France, 06189 Contact: Antoine Thyss, MD    33-04-9203-1538    antoine.thyss@cal.nice.fnclcc.fr    Hopital Europeen Georges Pompidou Recruiting Paris, France, 75015 Contact: Stephane Oudard, MD, PhD    33-1-56-093-476    stephane.oudard@hop.egp.ap-hop-paris.fr    Hopital Tenon Recruiting Paris, France, 75970 Contact: Jean-Pierre Lotz, MD    33-1-5601-6058    jean-pierre.lotz@tnn.ap-hop-paris.fr    Institut Jean Godinot Recruiting Reims, France, 51056 Contact: Jean-Christophe Eymard, MD    33-03-2650-4444    jc.eymard@reims.fnclcc.fr    Centre Eugene Marquis Recruiting Rennes, France, 35042 Contact: Pierre Kerbrat, MD, PhD    33-299-253-280    kerbrat@rennes.fnclcc.fr    Centre Hospitalier de Rodez Recruiting Rodez, France, 12027 Contact: Laurent Mosser    33-05-6575-1212       Centre Henri Becquerel Recruiting Rouen, France, 76038 Contact: Paule Chinet-Charrot    33-2-3208-2222       Institut Claudius Regaud Recruiting Toulouse, France, 31052 Contact: Christine Chevreau-Dalbianco, MD    33-56-142-4114    chevreau.christine@claudiusregaud.fr    Centre Hospitalier Universitaire Bretonneau de Tours Recruiting Tours, France, 37044 Contact: Claude Linassier, MD, PhD    33-2-4747-3827    linassier@med.univ-tours.fr    Centre Alexis Vautrin Recruiting Vandoeuvre-les-Nancy, France, 54511 Contact: Lionnel Geoffrois, MD    33-3-8359-8400       Institut Gustave Roussy Recruiting Villejuif, France, F-94805 Contact: Karim Fizazi, MD, PhD    33-1-4211-4559    fizazi@igr.fr    Slovakia National Cancer Institute - Bratislava Recruiting Bratislava, Slovakia, 833 10 Contact: Maria Reckova, MD    421-2-5937-8366    maria.reckova@nou.sk Less <<
NCT01083342 CNS Lymphoma Phase 2 Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of Less <<
NCT01458249 Soft Tissue Sarcoma Phase 2 Completed - Japan ... More >> Nagoya, Aichi, Japan Kashiwa, Chiba, Japan Hidaka, Hokkaido, Japan Sapporo, Hokkaido, Japan Tsu, Mie, Japan Suita, Osaka, Japan Bunkyo, Tokyo, Japan Chuo-ku, Tokyo, Japan Shinjuku, Tokyo, Japan Fukuoka, Japan Okayama, Japan Osaka, Japan Less <<
NCT00020722 - Terminated(Lack of funding to ... More >>continue study.) Less << - -
NCT02408042 Lymphoma Hodg... More >>kin's Lymphoma Non-hodgkin's Lymphoma Less << Phase 1 Phase 2 Withdrawn - United States, Arizona ... More >> Cancer Treatment Center of America @ Western Regional Medical Center Goodyear, Arizona, United States, 85338 Less <<
NCT03651375 Sarcoma Fibro... More >>sarcoma Leiomyosarcoma Liposarcoma Myosarcoma Histiocytic Sarcoma Synovial Sarcoma Lymphangiosarcoma Malignant Peripheral Nerve Sheath Tumors Myxofibrosarcoma Myxoid Liposarcoma Undifferentiated Sarcoma Pleomorphic Liposarcoma Undifferentiated Pleomorphic Sarcoma Dedifferentiated Liposarcoma Pleomorphic Rhabdomyosarcoma Malignant Triton Tumor Less << Phase 2 Recruiting March 2022 Poland ... More >> Maria Sklodowska-Curie Institute - Oncology Center Recruiting Warsaw, Mazovian, Poland, 02-781 Contact: Piotr Rutkowski, MD PhD Professor    +48226439375    piotr.rutkowski@coi.pl    Principal Investigator: Mateusz J Spałek, MD          Sub-Investigator: Hanna Koseła-Paterczyk, MD PhD          Sub-Investigator: Aneta Borkowska, MD          Sub-Investigator: Tadeusz Morysiński, MD PhD          Sub-Investigator: Anna Czarnecka, MD PhD          Sub-Investigator: Paweł Rogala, MD          Sub-Investigator: Monika Dudzisz-Śledź, MD PhD          Sub-Investigator: Tomasz Goryń, MD          Sub-Investigator: Maciej Sałamacha, MD          Sub-Investigator: Anna Szumera-Ciećkiewicz, MD PhD          Sub-Investigator: Michał Wągrodzki, MD          Sub-Investigator: Andrzej Cieszanowski, MD PhD Professor          Sub-Investigator: Patrycja Castaneda-Wysocka, MD          Sub-Investigator: Piotr Rutkowski, MD PhD Professor Less <<
NCT00072280 Sarcoma Phase 2 Terminated(Due to poor accrual... More >>) Less << - -
NCT01458249 - Completed - -
NCT00020722 Breast Cancer Phase 2 Terminated(Lack of funding to ... More >>continue study.) Less << - United States, Michigan ... More >> Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201-1379 Less <<
NCT00742924 Sarcoma Phase 1 Completed - -
NCT02066675 Metastatic and Locally Advance... More >>d Soft Tissue Tumor Patients Unfit to Receive Standard Chemotherapy Less << Phase 2 Completed - Italy ... More >> Ospedali Riuniti di Bergamo Bergamo, BG, Italy Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori - IRST Meldola, FC, Italy Ospedale Galliera Genova, Genovs, Italy IRCCS Azienda Ospedaliera Universitaria San Martino IST Genova, GE, Italy Ospedale Villa Scassi Genova, GE, Italy Ospedale Misericordia e Dolce" Istituto Toscano Tumori, Azienda USL4 Prato, PO, Italy I.R.C.C. - Unit of Medical Oncology Candiolo, Torino, Italy, 10060 Presidio Sanitario Gradenigo Torino, TO, Italy, 10153 A.S.O. "SS Antonio e Biagio e Cesare Arrigo" Alessandria, Italy Istituti Ortopedici Rizzoli - Unit of Chemotherapy of Muscoloskeletal Tumors Bologna, Italy, 40136 Ospedale SS. Trinità di Sora Frosinone, Italy IST Genova, Italy Policlinico Federico II Napoli Napoli, Italy Istituto Oncologico Veneto Padova, Italy Ospedale Giaccone Palermo, Italy Campus Biomedico Roma, Italy Less <<
NCT02099175 Sinonasal Tumors Phase 2 Active, not recruiting January 2024 Italy ... More >> Presidio Ospedaliero Spedali Civili di Brescia Brescia, BS, Italy, 25125 Fondazione IRCCS Istituto Nazionale Tumori Milano, MI, Italy, 20133 IRCCS Policlinico San Matteo Pavia, PV, Italy, 27100 A.O. Ospedale di Circolo e Fondazione Macchi Varese, VA, Italy, 21100 Azienda Ospedaliera "Maggiore della Carità" Novara, Italy, 28100 Less <<
NCT00072280 - Terminated(Due to poor accrual... More >>) Less << - -
NCT02099188 Unresectable Sinonasal Tumors Phase 2 Active, not recruiting January 2024 Italy ... More >> Presidio Ospedaliero Spedali Civili di Brescia Brescia, BS, Italy, 25125 Fondazione IRCCS Istituto Nazionale Tumori Milano, MI, Italy, 20133 IRCCS Policlinico San Matteo Pavia, PV, Italy, 27100 A.O. Ospedale di Circolo e Fondazione Macchi Varese, VA, Italy, 21100 Azienda Ospedaliera "Maggiore della Carità" Novara, Italy, 28100 Less <<
NCT00608803 Advanced Cancer Phase 1 Completed - United States, California ... More >> Santa Monica, California, United States, 90403 United States, Texas Houston, Texas, United States, 77024 Less <<
NCT00742924 - Completed - -
NCT00278278 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 3 Unknown - United States, Texas ... More >> M. D. Anderson Cancer Center at University of Texas Houston, Texas, United States, 77030-4009 Less <<
NCT00039130 Leukemia Lymp... More >>homa Less << Phase 2 Completed - -
NCT02771743 Newly Diagnosed High Risk Neur... More >>oblastoma Less << Phase 2 Recruiting March 2023 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of Contact: Ki Woong Sung    82-2-3410-3529    kwsped@skku.edu    Principal Investigator: Ki Woong Sung Less <<
NCT00039130 - Completed - -
NCT02784015 Unresectable Localized Soft Ti... More >>ssue Sarcoma Less << Phase 2 Recruiting May 2023 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of Contact: Ki Woong Sung    82-2-3410-3529    kwsped@skku.edu    Principal Investigator: Ki Woong Sung Less <<
NCT02131480 Uterus Leiomyosarcoma ... More >> Soft Tissue Leiomyosarcoma Less << Phase 2 Completed - France ... More >> Gustave Roussy Cancer Campus Grand Paris Villejuif, Val de Marne, France, 94805 Less <<
NCT00039195 - Completed - -
NCT00274924 Lymphoma Phase 2 Active, not recruiting March 2019 -
NCT00274924 - Active, not recruiting - -
NCT00039195 Lymphoma Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT02822404 Kidney Diseases Not Applicable Active, not recruiting September 2020 France ... More >> CHU Toulouse Toulouse, France, 31059 Less <<
NCT00126191 - Terminated(closed due to slow ... More >>accrual) Less << - -
NCT02367924 - Recruiting December 2020 Germany ... More >> Dokusan GmbH und Co. KG; Praxisklinik Herne / Onkologie Recruiting Herne, Nordrhein-Westfalen, Germany, 44623 Contact: Hahn Lars, Dr.    +49-2323 960 5340    l.hahn@dokusan.de    MVZ Marien-Hospital-Wesel GmbH Recruiting Wesel, Nordrhein-Westfalen, Germany, 46483 Contact: Mathias Hoiczyk, Dr.    +49-281-104 ext 1910    mathias.hoiczyk@prohomine.de    Onkologische Gemeinschaftspraxis Dr. med. Mohm & Dr. med. Prange-Krex Recruiting Dresden, Sachsen, Germany, 01307 Contact: Gabriele Prange-Krex, Dr.    +49-351 4416018    mohm@onkopraxis-dresden.de    Praxis Dr. med. Jens Uhlig Recruiting Naunhof, Sachsen, Germany, 04683 Contact: Jens Uhlig, Dr.    +49-34293 4799 76    dr.uhlig@onkologie-muldental.de    Praxis für Innere Medizin, Hämatologie u. Onkologie Recruiting Bremen, Germany, 28209 Contact: Gabriele Doering, Dr.    +49-421 696096 ext 24    dr.doering@nord-com.net Less <<
NCT03418038 High Grade B-Cell Lymphoma Wit... More >>h MYC and BCL2 or BCL6 Rearrangements Recurrent Diffuse Large B-Cell Lymphoma Recurrent Hodgkin Lymphoma Recurrent Lymphoma Refractory Diffuse Large B-Cell Lymphoma Refractory Lymphoma Less << Phase 2 Recruiting March 15, 2024 United States, Arizona ... More >> Mayo Clinic in Arizona Not yet recruiting Scottsdale, Arizona, United States, 85259 Contact: Clinical Trials Referral Office    855-776-0015       Principal Investigator: Craig B. Reeder          United States, Florida Mayo Clinic in Florida Not yet recruiting Jacksonville, Florida, United States, 32224-9980 Contact: Clinical Trials Referral Office    855-776-0015       Principal Investigator: Taimur Sher          United States, Iowa University of Iowa/Holden Comprehensive Cancer Center Not yet recruiting Iowa City, Iowa, United States, 52242 Contact: Umar Farooq       umar-farooq@uiowa.edu    Principal Investigator: Umar Farooq          United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Clinical Trials Referral Office    855-776-0015       Principal Investigator: Thomas E. Witzig Less <<
NCT01464606 Pleuropulmonary Blastoma Not Applicable Recruiting December 2019 United States, Minnesota ... More >> Children's Hospitals and Clinics of Minnesota Recruiting Minneapolis, Minnesota, United States, 55404 Contact: Gretchen M Williams, BS    612-813-7115    gretchen.williams@childrensmn.org    Contact: Kris Ann P Schultz, MD    612-813-7121    krisann.schultz@childrensmn.org    Principal Investigator: Kris Ann P Schultz, M.D. Less <<
NCT00002835 Lymphoma Phase 3 Completed - United States, Texas ... More >> University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 Less <<
NCT01508312 Hodgkin's Lymphoma Phase 2 Active, not recruiting September 2019 United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT01505569 Ewing's Family Tumors ... More >> Renal Tumors Hepatoblastoma Rhabdomyosarcoma Soft Tissue Sarcoma Primary Malignant Brain Neoplasms Retinoblastoma Medulloblastoma Supra-tentorial Primative Neuro-Ectodermal Tumor (PNET) Atypical Teratoid/Rhabdoid Tumor (AT/RT) CNS Tumors Germ Cell Tumors Less << Not Applicable Recruiting January 2021 United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Kim Nelson    612-273-2925    knelso62@fairview.org    Principal Investigator: Heather Stefanski, MD, PhD Less <<
NCT00126191 Burkitt Lymphoma ... More >> Non-Hodgkins Lymphoma Atypical Burkitt Lymphoma Less << Phase 2 Terminated(closed due to slow ... More >>accrual) Less << - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT02329080 Diffuse Large B-cell Lymphoma Phase 2 Recruiting December 2023 Czechia ... More >> Facultni nemocnice Recruiting Brno, Czechia Contact: Andrea Janikova          Principal Investigator: Andrea Janikova          FNKV (Facultni Nemocnice Kralovske Vinohrady) Recruiting Praha, Czechia Contact: Heidi Mocikova          Principal Investigator: Heidi Mocikova          Vseobecna facultni nemocnice v Praze Not yet recruiting Praha, Czechia Contact: Robert Pytlik          Principal Investigator: Robert Pytlik          Italy Spedali Civili Recruiting Brescia, Italy Contact: Giuseppe Rossi          Principal Investigator: Giuseppe Rossi          UO Ematologia e CTMO, PO Businco Recruiting Cagliari, Italy Contact: Giuseppina Cabras          Principal Investigator: Giuseppina Cabras          IRST Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori Recruiting Meldola, Italy Contact: Gerardo Musuraca          Principal Investigator: Gerardo Musuraca          UO Ematoliga Ospedale dell'Angelo Recruiting Mestre, Italy Contact: Renato Bassan          Principal Investigator: Renato Bassan          Istituto Nazionale Tumori Recruiting Milano, Italy Principal Investigator: Liliana Devizzi          Ospedale Maggiore Policlinico Recruiting Milano, Italy Contact: Maria Cecilia Goldaniga          Principal Investigator: Maria Cecilia Goldaniga          San Raffaele H Scientific Institute Recruiting Milan, Italy Contact: Andres Ferreri, MD       ferreri.andres@hsr.it    Principal Investigator: Andrés JM Ferreri, MD          AOU Policlinico di Modena Recruiting Modena, Italy Contact: Franco Narni          Principal Investigator: Franco Narni          SCDU Ematologia Recruiting Novara, Italy Contact: Gianluca Gaidano          Principal Investigator: Gianluca Gaidano          Ematologia ed Immunologia Clinica - AO di Padova Recruiting Padova, Italy Contact: Renato Zambello          Principal Investigator: Renato Zambello          UO Oncoematologia Ospedale Tortora Recruiting Pagani, Italy Contact: Catello Califano          Principal Investigator: Catello Califano          Villa Sofia - Cervello Recruiting Palermo, Italy Contact: Caterina Patti          Principal Investigator: Caterina Patti          Ematologia AOU Recruiting Parma, Italy Contact: Francesca Re          Principal Investigator: Francesca Re          Ematologia Ospedale S.Maria delle Croci Recruiting Ravenna, Italy Contact: Claudia Cellini          Principal Investigator: Claudia Cellini          A.O. Bianchi-Melacrino-Morelli, Divisione di Ematologia Recruiting Reggio Calabria, Italy Contact: Caterina Stelitano, MD          Principal Investigator: Caterina Stelitano, MD          Arcispedale Santa Maria Nuova, Azienda Ospedaliera di Reggio Emilia Recruiting Reggio Emilia, Italy Contact: Fiorella Ilariucci          Principal Investigator: Fiorella Ilariucci          Ematologia Università La Sapienza Recruiting Roma, Italy Contact: Maurizio Martelli          Principal Investigator: Maurizio Martelli          IRCCS Istituto Regina Elena (IFO) Recruiting Roma, Italy Contact: Francesca Palombi          Principal Investigator: Francesca Palombi          Policlinico Universitario Campus Bio-Medico Recruiting Rome, Italy Contact: Ombretta Annibali          Principal Investigator: Ombretta Annibali          IRCCS Casa Sollievo Della Sofferenza Recruiting San Giovanni Rotondo, Italy Contact: Nicola Cascavilla          Principal Investigator: Nicola Cascavilla          AOU Senese Recruiting Siena, Italy Contact: Alberto Fabbri          Principal Investigator: Alberto Fabbri          AO S.Maria di Terni Recruiting Terni, Italy Contact: Anna Marina Liberati          Principal Investigator: Anna Marina Liberati          SC Ematologia AO Città della Salute e della Scienza Recruiting Torino, Italy Contact: Barbara Botto          Principal Investigator: Barbara Botto          UO Ematologia Ospedale Panico Recruiting Tricase, Italy Contact: Vincenzo Pavone          Principal Investigator: Vincenzo Pavone          AOU Santa Maria della Misericordia Recruiting Udine, Italy Contact: Francesco Zaja          Principal Investigator: Francesco Zaja          UOC Ematologia Policlinico Rossi Recruiting Verona, Italy Contact: Achille Ambrosetti          Principal Investigator: Achille Ambrosetti          Ematologia Ospedale S. Bortolo Recruiting Vicenza, Italy Contact: Maurizio Frezzato          Principal Investigator: Maurizio Frezzato          Netherlands Erasmus MC Recruiting Rotterdam, Netherlands Contact: Jeanette Doorduijn          Principal Investigator: Jeanette Doorduijn          United Kingdom Beatson Cancer Center Recruiting Glasgow, United Kingdom Contact: Pam Mc Kay          Principal Investigator: Pam Mc Kay          Liverpool Aintree Recruiting Liverpool, United Kingdom Contact: Jeffery Smith          Principal Investigator: Jeffery Smith          UCLH University College London Hospitals NHS foundation trust Recruiting London, United Kingdom Contact: Kate Cwynarski          Principal Investigator: Kate Cwynarski          The Christie Hospital Recruiting Manchester, United Kingdom Contact: Kim Linton          Principal Investigator: Kim Linton          Southampton General Hospital Not yet recruiting Southampton, United Kingdom Contact: Andrew Davies          Principal Investigator: Andrew Davies Less <<
NCT01795430 Adult Supratentorial Primitive... More >> Neuroectodermal Tumor (PNET) Ewing Sarcoma of Bone Extraosseous Ewing Sarcoma Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor Less << Not Applicable Withdrawn(No participants enro... More >>lled.) Less << - United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010 Less <<
NCT00809341 Non-Hodgkin's Lymphoma Phase 2 Terminated(Low accrual) - United States, Maryland ... More >> The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231 Less <<
NCT02638428 Relapsed Pediatric Solid Tumor... More >> Refractory Pediatric Solid Tumor Relapsed Pediatric AML Refractory Pediatric AML Less << Phase 2 Recruiting December 2023 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of Contact: Ki Woong Sung    82-2-3410-3529    kwsped@skku.edu    Principal Investigator: Ki Woong Sung Less <<
NCT01055314 - Completed - -
NCT01979536 Anaplastic Large Cell Lymphoma... More >>, ALK-Positive Ann Arbor Stage II Noncutaneous Childhood Anaplastic Large Cell Lymphoma Ann Arbor Stage III Noncutaneous Childhood Anaplastic Large Cell Lymphoma Ann Arbor Stage IV Noncutaneous Childhood Anaplastic Large Cell Lymphoma CD30-Positive Neoplastic Cells Present Less << Phase 2 Recruiting December 31, 2021 -
NCT01148173 Lymphoma, Non-Hodgkin Phase 2 Unknown October 2012 Germany ... More >> Charité Universitätsmedizin Recruiting Berlin, Germany, 12200 Contact: Lars Fischer, MD    +49308445 ext 4096    lars.fischer@charite.de    Contact: Agnieszka Korfel, MD    +49308445 ext 4096    agnieszka.korfel@charite.de Less <<
NCT00809341 - Terminated(Low accrual) - -
NCT01055314 Adult Rhabdomyosarcoma ... More >> Childhood Alveolar Rhabdomyosarcoma Childhood Embryonal Rhabdomyosarcoma Metastatic Childhood Soft Tissue Sarcoma Stage IV Adult Soft Tissue Sarcoma Untreated Childhood Rhabdomyosarcoma Less << Phase 2 Completed - -
NCT00186849 Neuroblastoma Phase 2 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00047320 Brain Tumor C... More >>entral Nervous System Tumors Childhood Germ Cell Tumor Less << Phase 2 Completed - -
NCT00797810 Acute Lymphoblastic Leukemia ... More >> Non-Hodgkin's Lymphoma Less << Phase 4 Unknown - Italy ... More >> Institute of Haematology "L. e A. Seragnoli" Recruiting Bologna, Italy Contact: Giovanni Martinelli, MD Less <<
NCT00061893 - Completed - -
NCT00061893 Sarcoma Phase 2 Completed - -
NCT02422563 Cervical Cancer Phase 3 Not yet recruiting October 2025 -
NCT00047320 - Completed - -
NCT00006734 Sarcoma Phase 3 Completed - -
NCT01864109 Newly Diagnosed Ewing Sarcoma Phase 2 Recruiting May 2020 United States, New Jersey ... More >> Memoral Sloan Kettering Cancer Center Recruiting Basking Ridge, New Jersey, United States, 07920 Contact: Paul Meyers, MD    212-639-5952       Memorial Sloan Kettering Monmouth Recruiting Middletown, New Jersey, United States, 07748 Contact: Paul Meyers, MD    212-639-5952       United States, New York Memorial Sloan Kettering Commack Recruiting Commack, New York, United States, 11725 Contact: Paul Meyers, MD    212-639-5952       Memorial Sloan Kettering Westchester Recruiting Harrison, New York, United States, 10604 Contact: Paul Meyers, MD    212-639-5952       Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Paul Meyers, MD    212-639-5952       Contact: Emily Slotkin, MD    212-639-8856       Principal Investigator: Paul Meyers, MD          Memorial Sloan Kettering Rockville Centre Recruiting Rockville Centre, New York, United States, 11570 Contact: Paul Meyers, MD    212-639-5952 Less <<
NCT02727387 Ewing's Sarcoma (ES) Phase 2 Recruiting May 2020 Italy ... More >> Centro di Riferimento Oncologico - Unit of Medical Oncology Not yet recruiting Aviano, Pordenone, Italy, 33081 Contact: Maurizio Mascarin, MD    +390434659 ext 536    mascarin@cro.it    Principal Investigator: Maurizio Mascarin, MD          I.R.C.C. - Unit of Medical Oncology Recruiting Candiolo, Torino, Italy, 10060 Contact: Massimo Aglietta, MD    +39.011.9933 ext 628    massimo.aglietta@ircc.it    Principal Investigator: Massimo Aglietta, MD          Sub-Investigator: Giovanni Grignani, MD          Istituto Ortopedico Rizzoli - Unit of Chemotherapy of Muscoloskeletal Tumors Recruiting Bologna, Italy, 40136 Contact: Stefano Ferrari, MD    +390516366199 ext 199    stefano.ferrari@ior.it    Principal Investigator: Stefano Ferrari, MD          Servizio di Oncoematologi Pediatrica Ospedale microcitemico ASL 8 Recruiting Cagliari, Italy, Rosamaria Contact: Rosamaria Mura, MD    +39070504208       Principal Investigator: Rosamaria Mura, MD          A.O. Universitaria Meyer Recruiting Firenze, Italy, 50139 Contact: Angela Tamburini, MD    +3905556 ext 621    a.tamburini@meyer.it    Principal Investigator: Angela Tamburini, MD          Istituto Giannina Gaslini Recruiting Genova, Italy Contact: Carla Manzitti, MD    0105636 2431       Principal Investigator: Carla Manzitti, MD          Fondazione IRCCS INT Milano Recruiting Milano, Italy Contact: Rossella Bertulli, MD    +390223903 ext 287    rossella.bertulli@istitutotumori.mi.it    Principal Investigator: Rossella Bertulli, MD          Fondazione IRCCS INT Milano Recruiting Milano, Italy Contact: Roberto Luksch, MD    +390223903       Principal Investigator: Roberto Luksch, MD          Ospedale Pediatrico Bambin Gesu' Recruiting Roma, Italy Contact: Raffaele Cozza, MD    +39065266919       Principal Investigator: Raffaele Cozza, MD          Ospedale Infantile Regina Margherita - Unit of Paediatric Oncoematology Recruiting Torino, Italy, 10126 Contact: Franca Fagioli, MD    +39.011.3135 ext 230    franca.fagioli@unito.it    Principal Investigator: Franca Fagioli, MD Less <<
NCT02471911 Diffuse Large B-Cell Lymphoma Phase 1 Recruiting June 2020 United States, New York ... More >> Weill Cornell Medical College Recruiting New York, New York, United States, 10021 Contact: Amelyn Rodriguez, RN    212-746-1362       Contact: Rita Gazivoda, RN    212-746-0702 Less <<
NCT00623077 Brain and Central Nervous Syst... More >>em Tumors Kidney Cancer Liver Cancer Retinoblastoma Sarcoma Less << Phase 1 Terminated(Replaced by another... More >> study) Less << - United States, Minnesota ... More >> Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT00006708 Lymphoma Phase 3 Terminated(lack of accrual) - -
NCT00086944 Recurrent Adult Diffuse Large ... More >>Cell Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Less << Phase 1 Phase 2 Completed - United States, Illinois ... More >> University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637-1470 Less <<
NCT00002816 Leukemia Phase 3 Completed - -
NCT00435578 Carcinoma, Small Cell Lung Phase 2 Terminated - United States, California ... More >> California Cancer Center Greenbrae, California, United States, 94904 United States, Florida H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 United States, Michigan Karmanos Cancer Institute Detroit, Michigan, United States, 48201 Less <<
NCT00442598 Ovarian Cancer Phase 2 Terminated - United States, Arizona ... More >> Premiere Oncology of Arizona Scottsdale, Arizona, United States, 85260 Arizona Cancer Center Tucson, Arizona, United States, 85724 United States, California California Cancer Center Greenbrae, California, United States, 94904 UCI Chao Family Comprehensive Cancer Center Orange, California, United States, 92868 United States, Indiana Indiana University Cancer Center Indianapolis, Indiana, United States, 46202 United States, Kentucky Louisville Oncology Clinical Research Program Louisville, Kentucky, United States, 40202 United States, New Mexico New Mexico Cancer Care Alliance Albuquerque, New Mexico, United States, 87106 United States, Ohio Gabrail Cancer Center Canton, Ohio, United States, 44718 United States, South Carolina Gynecologic Oncology Research & Development, LLC Greenville, South Carolina, United States, 29601 United States, Texas Harrington Cancer Center Amarillo, Texas, United States, 79106 Less <<
NCT01696669 Ewing's Sarcoma Phase 2 Completed - Spain ... More >> Hospital Clínic de Barcelona Barcelona, Spain Hospital de la Santa Creu i Sant Pau Barcelona, Spain Hospital Vall d'Hebron Barcelona, Spain Hospital Sant Joan de Déu Esplugues de Llobregat, Spain Institut Català d'Oncologia l'Hospitalet Hospitalet de Llobregat, Spain Hospital Universitario de Canarias La Laguna, Spain Hospital Ramón y Cajal Madrid, Spain, 28034 Hospital Son Espases Palma de Mallorca, Spain Hospital Universitario Miguel Servet Zaragoza, Spain Less <<
NCT01946529 Desmoplastic Small Round Cell ... More >>Tumor Ewing Sarcoma of Bone or Soft Tissue Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Less << Phase 2 Active, not recruiting July 2026 United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00442598 - Terminated - -
NCT01333605 Hodgkin Lymphoma Phase 2 Unknown June 2014 China ... More >> Fudan University Shanghai Cancer Center Recruiting Shanghai, China, 200032 Contact: Ye Guo, MD    86 21 64175590 ext 8906    pattrick_guo@msn.com Less <<
NCT00231582 Testicular Neoplasms Phase 2 Completed - France ... More >> Hôpital TENON, Service d'Oncologie Médicale Paris, France, 75020 Less <<
NCT00293358 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 3 Completed - Ireland ... More >> Our Lady's Hospital for Sick Children Dublin, Ireland, 12 United Kingdom Birmingham Children's Hospital Birmingham, England, United Kingdom, B4 6NH Institute of Child Health at University of Bristol Bristol, England, United Kingdom, BS2 8AE Addenbrooke's Hospital at Cambridge University Hospitals NHS Foundation Trust Cambridge, England, United Kingdom, CB2 2QQ Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Leicester Royal Infirmary Leicester, England, United Kingdom, LE1 5WW Royal Liverpool Children's Hospital, Alder Hey Liverpool, England, United Kingdom, L12 2AP Royal London Hospital London, England, United Kingdom, E1 1BB Great Ormond Street Hospital for Children NHS Trust London, England, United Kingdom, WC1N 3JH Central Manchester and Manchester Children's University Hospitals NHS Trust Manchester, England, United Kingdom, M27 4HA Sir James Spence Institute of Child Health Newcastle-Upon-Tyne, England, United Kingdom, NE1 4LP Queen's Medical Centre Nottingham, England, United Kingdom, NG7 2UH Oxford Radcliffe Hospital Oxford, England, United Kingdom, 0X3 9DU Children's Hospital - Sheffield Sheffield, England, United Kingdom, S10 2TH Southampton General Hospital Southampton, England, United Kingdom, SO16 6YD Royal Marsden NHS Foundation Trust - Surrey Sutton, England, United Kingdom, SM2 5PT Royal Belfast Hospital for Sick Children Belfast, Northern Ireland, United Kingdom, BT12 6BE Royal Aberdeen Children's Hospital Aberdeen, Scotland, United Kingdom, AB25 2ZG Royal Hospital for Sick Children Edinburgh, Scotland, United Kingdom, EH9 1LF Royal Hospital for Sick Children Glasgow, Scotland, United Kingdom, G3 8SJ Childrens Hospital for Wales Cardiff, Wales, United Kingdom, CF14 4XW Less <<
NCT01136824 - Completed - United States, Pennsylvania ... More >> University of Pittsburgh, Hillman Cancer Center Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT01650077 - Unknown December 2014 France ... More >> Bergonie Institute Bordeaux, France, 33 076 Oscar Lambret Center Lille, France, 59020 Cancer Institute of the West Nantes - Saint Therblain, France, 44 805 Antoine Lacassagne Center Nice, France, 06 189 Curie Institute Paris, France, 75 005 Henri Becquerel Center Rouen, France, 76 038 Less <<
NCT01667302 Extranodal NK/T-cell Lymphoma,... More >> Nasal Type Less << Phase 2 Unknown December 2016 China, Shanghai ... More >> Fudan University Cancer Hospital Recruiting SHanghai, Shanghai, China, 200032 Contact: Ye Guo, MD    862164175590    pattrick_guo@msn.com Less <<
NCT01946529 - Active, not recruiting - -
NCT01238159 Extranodal NK-T-Cell Lymphoma,... More >> Nasal and Nasal-Type Less << Phase 2 Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of, 135710 Less <<
NCT02686346 Hodgkin Disease Phase 1 Phase 2 Active, not recruiting July 2021 Belgium ... More >> Clinique Universitaire Saint-Luc Bruxelles, Belgium, 1200 CHU Dinant Godinne Yvoir, Belgium, 5530 France Institut d'Hématologie de Basse Normandie - CHU Côte de Nacre Caen, France, 14033 APHP-Hôpital Henri Mondor Créteil, France, 94010 CHU de Dijon - Hôpital le Bocage Dijon, France, 21000 CHRU Lille - Hôpital Claude Huriez Lille, France, 59037 Centre Léon Bérard Lyon, France, 69373 CHU Saint Eloi Montpellier, France, 34295 CHU De Nantes Nantes, France, 44093 APHP - Hôpital Saint Louis PARIS Cedex 10, France, 75475 Hôpital Necker Paris, France, 75015 CHU Lyon Sud Pierre Bénite Cedex, France, 69495 CHU de Poitiers - Hôpital de La Milétrie Poitiers, France, 86021 CHU De Rennes Rennes, France, 35033 Centre Henri Becquerel Rouen, France, 76000 CHU De Strasbourg Strasbourg, France, 67098 IUCT Toulouse Toulouse, France, 31100 CHU De Nancy - Hôpital Brabois Vandœuvre-lès-Nancy, France, 54511 Institut Gustave Roussy VILLEJUIF Cedex, France, 94085 Less <<
NCT02432274 Tumors Solid ... More >>Malignant Tumors Osteosarcoma Differentiated Thyroid Cancer (DTC) Less << Phase 1 Phase 2 Recruiting December 31, 2019 United States, Texas ... More >> Texas Children's Hospital Recruiting Houston, Texas, United States France CHU Strasbourg - Hopital Hautepierre Recruiting Strasbourg, Bas Rhin, France Centre Oscar Lambret Lille Recruiting Lille, Rhone, France Centre Leon Berard Recruiting Lyon, Rhone, France CHU Nantes - Hopital Mere-Enfant Recruiting Nantes, France Institut Curie - Centre de Lutte Contre le Cancer (CLCC) de Paris Recruiting Paris, France Institut Gustave Roussy Recruiting Paris, France CHU de Toulouse - Hopital des Enfants Recruiting Toulouse, France Germany Universitaetsklinikum Muenster Recruiting Muenster, Germany Kinderklinik des Olga hospitals Recruiting Stuttgart, Germany Italy Istituto Ortopedico Rizzoli Recruiting Bologna, Italy Fondazione IRCCS Istituto Nazionale dei Tumori Recruiting Milan, Italy Ospedale Pediatrico Bambino Gesu Recruiting Roma, Italy Spain Hospital Universitari Vall d'Hebron Recruiting Barcelona, Spain Hospital Infantil Universitario Nino Jesus Recruiting Madrid, Spain Hospital Universitario y Politecnico La Fe Hospital La Fe Valencia Recruiting Valencia, Spain United Kingdom Birmingham Children's Hospital Recruiting Birmingham, United Kingdom University College London Hospital Recruiting London, United Kingdom Royal Victoria Infirmary Recruiting Newcastle, United Kingdom Less <<
NCT03390946 Osteosarcoma ... More >>Feasibility Treatment Response Biomarker Less << Phase 2 Not yet recruiting December 31, 2020 Korea, Republic of ... More >> National Cancer Center Not yet recruiting Goyang-si, Gyeonggi, Korea, Republic of, 10408 Contact: Byung-Kiu Park, M.D., Ph.D.    82-31-920-1240    bkpark@ncc.re.kr    Contact: Mi Mi Kwon, RN    82-31-920-1240    rnjsalal@ncc.re.kr Less <<
NCT02014831 Squamous Cell Carcinoma of the... More >> Penis Less << Phase 2 Withdrawn(Industry decline to ... More >>supply study drug) Less << - France ... More >> CHRU Strasbourg Strasbourg, Bas Rhin, France, 67098 Institut Paoli Calmettes Marseille, Bouches du Rhône, France, 13273 Institut Bergonié Bordeaux, Gironde, France, 33076 Institut Claudius Regaud Toulouse, Haute Garonne, France, 31052 Institut Curie Paris, Ile de France, France, 75005 APHP Hôpital Saint Louis Paris, Ile de France, France, 75475 Centre Léon Bérard Lyon, Rhône, France, 69373 Less <<
NCT00439686 Advanced Sarcoma PHASE1|PHASE2 COMPLETED 2025-12-13 Santa Monica, California, Unit... More >>ed States|Ann Arbor, Michigan, United States Less <<
NCT03367143 Diffuse Large B-Cell Lymphoma ... More >>Refractory Less << Phase 2 Recruiting December 2019 China, Shanghai ... More >> Shanghai Ruijin Hospital Recruiting Shanghai, Shanghai, China, 200025 Contact: Weili Zhao, MD, PhD    64370045 ext 610707    Zhao.weili@yahoo.com    Contact: Pengpeng Xu, MD    64370045 ext 610707    Xpproc@msn.com Less <<
NCT01979393 Uterine Sarcoma Phase 2 Recruiting July 2019 Belgium ... More >> Universitair Ziekenhuis Antwerpen Recruiting Edegem, Belgium Principal Investigator: Manon Huizing          France Institut Bergonie Recruiting Bordeaux, France, 33076 Contact: Contact Person    33-556-333-333       Principal Investigator: Anne Floquet          Centre Georges-Francois-Leclerc Recruiting Dijon, France, 21079 Principal Investigator: Nicolas Isambert          Centre Leon Berard Recruiting Lyon, France, 69373 Contact: Contact Person    33-4-7878-2645       Principal Investigator: Isabelle Ray-Coquard          Institut de Cancerologie de l'Ouest (ICO) - Centre Rene Gauducheau Recruiting Nantes, France Principal Investigator: Emmanualle Bompas          Italy Fondazione IRCCS Istituto Nazionale dei Tumori Recruiting Milano, Italy, 20133 Principal Investigator: Paolo Casali          Netherlands Academisch Medisch Centrum at University of Amsterdam Recruiting Amsterdam, Netherlands, 1105 AZ Principal Investigator: Anneke Westermann, MD          Spain Hospital General Vall D'Hebron Recruiting Barcelona, Spain, 08035 Principal Investigator: Claudia Valverde          Hospital Universitario San Carlos Recruiting Madrid, Spain, 28040 Principal Investigator: Antonio Casado          United Kingdom Cambridge University Hospital NHS - Addenbrookes Hospital Recruiting Cambridge, United Kingdom Principal Investigator: Helena Earl          NHS Greater Glasgow and Clyde - Beatson West of Scotland Cancer Centre - Gartnavel General Hospital Recruiting Glasgow, United Kingdom Principal Investigator: Nick Reed Less <<
NCT02180867 Adult Fibrosarcoma ... More >> Alveolar Soft Part Sarcoma Angiomatoid Fibrous Histiocytoma Atypical Fibroxanthoma Clear Cell Sarcoma of Soft Tissue Epithelioid Malignant Peripheral Nerve Sheath Tumor Epithelioid Sarcoma Extraskeletal Myxoid Chondrosarcoma Extraskeletal Osteosarcoma Fibrohistiocytic Neoplasm Glomus Tumor of the Skin Inflammatory Myofibroblastic Tumor Intimal Sarcoma Leiomyosarcoma Liposarcoma Low Grade Fibromyxoid Sarcoma Low Grade Myofibroblastic Sarcoma Malignant Cutaneous Granular Cell Tumor Malignant Peripheral Nerve Sheath Tumor Malignant Triton Tumor Mesenchymal Chondrosarcoma Myxofibrosarcoma Myxoid Chondrosarcoma Myxoinflammatory Fibroblastic Sarcoma Nerve Sheath Neoplasm PEComa Pericytic Neoplasm Plexiform Fibrohistiocytic Tumor Sclerosing Epithelioid Fibrosarcoma Stage IB Soft Tissue Sarcoma AJCC v7 Stage IIB Soft Tissue Sarcoma AJCC v7 Stage III Soft Tissue Sarcoma AJCC v7 Stage IV Soft Tissue Sarcoma AJCC v7 Synovial Sarcoma Undifferentiated (Embryonal) Sarcoma Undifferentiated High Grade Pleomorphic Sarcoma of Bone Less << Phase 2 Phase 3 Suspended(Scheduled Interim Mo... More >>nitoring) Less << - -
NCT01459484 Osteosarcoma Phase 2 Phase 3 Recruiting February 2020 Italy ... More >> I.R.C.C. - Unit of Medical Oncology Not yet recruiting Candiolo, Torino, Italy, 10060 Contact: Giovanni Grignani, MD    +39.011.9933 ext 278    giovanni.grignani@ircc.it    Contact: Luisa Gioeni, Pharmacist    +39.011.9933 ext 278    luisa.gioeni@ircc.it    Sub-Investigator: Giovanni Grignani, MD          Principal Investigator: Massimo Aglietta, MD          Presidio Sanitario Gradenigo Not yet recruiting Torino, TO, Italy, 10153 Contact: Alessandro Comandone, MD    +390118151 ext 211    alessandro.comandone@gradenigo.it    Principal Investigator: Alessandro Comandone, MD          Istituto Ortopedico Rizzoli Recruiting Bologna, Italy, 40136 Contact: Stefano Ferrari, MD    +390516366 ext 411    stefano.ferrari@ior.it    Contact: Emanuela Marchesi, PhD    +390516366 ext 400    emanuela.marchesi@ior.it    Principal Investigator: Stefano Ferrari, MD          A.O. Universitaria Meyer Recruiting Firenze, Italy, 50139 Contact: Angela Tamburini, MD    +3905556 ext 621    a.tamburini@meyer.it    Principal Investigator: Angela Tamburini, MD          Istituto Giannina Gaslini Not yet recruiting Genova, Italy Contact: Carla Manzitti, MD          Principal Investigator: Carla Manzitti, MD          FONDAZIONE IRCCS Istituto Nazionale dei Tumori Recruiting Milano, Italy Contact: Rossella Bertulli, MD          Principal Investigator: Rossella Bertulli, MD          FONDAZIONE IRCCS Istituto Nazionale dei Tumori Recruiting Milano, Italy Contact: Roberto Luksch, MD          Principal Investigator: Roberto Luksch, MD          Istituto Nazionale Tumori "Fondazione G. Pascale" Not yet recruiting Napoli, Italy, 80131 Contact: Gaetano Apice, MD          Principal Investigator: Gaetano Apice, MD          Azienda Ospedaliera di Padova Recruiting Padova, Italy Contact: Gianni Bisogno, MD          Principal Investigator: Gianni Bisogno, MD          Istituti Fisioterapici Ospitalieri di Roma Recruiting Roma, Italy Contact: Virginia Ferraresi, MD          Principal Investigator: Virginia Ferraresi, MD          Ospedale Pediatrico Bambin Gesu' Recruiting Roma, Italy Contact: Raffaele Cozza, MD          Principal Investigator: Raffaele Cozza, MD          Ospedale Infantile Regina Margherita - Unit of Paediatric Oncoematology Recruiting Torino, Italy, 10126 Contact: Franca Fagioli, MD    +39.011.3135 ext 230    franca.fagioli@unito.it    Principal Investigator: Franca Fagioli, MD Less <<
NCT01602666 Central Nervous System Nongerm... More >>inomatous Germ Cell Tumor Childhood Central Nervous System Germinoma Less << Phase 2 Suspended(Scheduled Interim Mo... More >>nitoring) Less << - -
NCT00712582 Non-Hodgkin's Lymphoma Phase 2 Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT01382030 Soft Tissue Sarcoma Phase 2 Completed - Germany ... More >> Heidelberg University Clinics Heidelberg, Baden-Wuerttemberg, Germany, 69120 Less <<
NCT02249702 Leiomyosarcoma Phase 2 Completed - Italy ... More >> Centro di Riferimento Oncologico Aviano, Pordenone, Italy Policlinico Umberto I Roma, RM, Italy, 00186 Fondazione del Piemonte per l'Oncologia Candiolo, Turin, Italy Azienda ULSS 13 Regione Veneto, Ospedale di Mirano Mirano, Venice, Italy Ospedale Sacro Cuore Don Calabria Negrar, Verona, Italy Azienda Ospedaliera Nazionale SS. Antonio e Biagio e C. Arrigo Alessandria, Italy Azienda Ospedaliera Spedali Civili di Brescia Brescia, Italy Presidio Ospedaliero Senatore Antonio Perrino Brindisi, Italy Azienda Ospedaliera per l'Emergenza Cannizzaro Catania, Italy Ospedale Sant'Anna Como, Italy Azienda Ospedaliera S. Croce e Carle Cuneo, Italy Azienda Ospedaliera Universitaria San Martino - IST Genoa, Italy Ente Ospedaliero Ospedali Galliera Genova, Italy Azienda USL 2 Toscana - Nuovo Ospedale San Luca Lucca, Italy Istituto Nazionale dei Tumori di Milano Milano, Italy Istituto Clinico Humanitas Milan, Italy Istituto Europeo di Oncologia Milan, Italy Istituto Nazionale dei Tumori di Milano Milan, Italy Azienda Ospedaliera San Gerardo Monza, Italy Istituto Nazionale Tumori - Fondazione Pascale Napoli, Italy Azienda Ospedaliero Universitaria Maggiore della Carità Novara, Italy Istituto Oncologico Veneto Padova, Italy Azienda Ospedaliera Ospedali Riuniti Villa Sofia - Cervello Palermo, Italy Azienda Ospedaliero-Universitaria di Parma Parma, Italy Policlinico San Matteo Pavia, Italy Azienda Ospadaliero-Universitaria Pisana Pisa, Italy Azienda Ospedaliera Regionale San Carlo Potenza, Italy Azienda Ospedaliera Arcispedale S. Maria Nuova Reggio Emilia, Italy Ospedale San Giovanni Calibita Fatebenefratelli Roma, Italy Policlinico Umberto I - Università Sapienza Roma, Italy Policlinco Universitario Agostino Gemelli Rome, Italy Azienda Ospedaliera Ordine Mauriziano Torino, Italy Azienda Ospedaliero-Universitaria di Torino - Presidio Sant'Anna Torino, Italy Presidio Sanitario Gradenigo Torino, Italy Less <<
NCT03711279 Sarcoma Phase 2 Not yet recruiting September 15, 2022 China, Shanghai ... More >> Shanghai Jiao Tong University Affiliated Sixth People's Hospital Not yet recruiting Shanghai, Shanghai, China Contact: Yang Yao, M.D.       Yangyao_6@hotmail.com    Principal Investigator: Yang Yao, M.D. Less <<
NCT00529503 Lymphoma, Large B-Cell, Diffus... More >>e Lymphoma, Non-Hodgkin Less << Phase 2 Terminated - -
NCT00324467 Lymphoma, Non-Hodgkin ... More >> Advanced Stage Diffuse Large B-Cell Non-Hodgkin's Lymphoma Less << Phase 2 Active, not recruiting December 2018 Canada, British Columbia ... More >> BC Cancer Agency Vancouver, British Columbia, Canada, V5Z 4E6 Less <<
NCT02817958 Penile Cancer ... More >> Squamous Carcinoma Less << Phase 2 Recruiting September 2022 France ... More >> ICO-Paul Papin Recruiting Angers, France, 49055 Contact: Emmanuelle BOMPAS, Doctor    +33(0)2 41 35 27 00    emmanuelle.bompas@ico.unicancer.fr    Chr Besancon Recruiting Besançon, France, 25000 Contact: Tristant MAURINA, Doctor    +33(0)3 81 66 93 67    t1maurina@chu-besancon.fr    Hôpital SAINT ANDRE Recruiting Bordeaux, France, 33075 Contact: Amaury DASTE, Doctor       amaury.daste@chu-bordeaux.fr    Centre FRANCOIS BACLESSE Recruiting Caen, France, 14076 Contact: Florence JOLY, Prof    +33 2 31 45 50 02    f.joly@baclesse.unicancer.fr    Chru Gabriel Montpied Recruiting Clermont Ferrand, France, 63000 Contact: Laurent GUY, Professor    +33(0)4 73 75 14 97    lguy@chu-clermontferrand.fr    Ch de Limoges Recruiting Limoges, France, 87042 Contact: Aurélien DESCAZEAUD, Professor    +33(0)5 55 05 80 15    aurelien.descazeaud@chu-limoges.fr    Centre Leon Berard Recruiting Lyon, France, 69008 Contact: Aude FLECHON, Doctor    +33(0)4 78 78 26 43    aude.flechon@lyon.unicancer.fr    Chu Lyon Sud Recruiting Lyon, France, 69310 Contact: Jean-Etienne TERRIER, Dr    +33 4 72 67 88 01    jean-etienne.terrier01@chu-lyon.fr    Institut Paoli-Calmettes Recruiting Marseille, France, 13273 Contact: Gwenaelle GRAVIS, Doctor    +33(0)4 91 22 37 40    gravisg@ipc.unicancer.fr    Institut de Cancerologie de Lorraine Recruiting Nancy, France, 54519 Contact: Vincent MASSARD, Dr    +33 3 23 59 84 61    v.massard@nancy.unicancer.fr    Clinique Urologique- Chu Hotel Dieu Recruiting Nantes, France, 44093 Contact: Jérôme RIGAUD, Professor    +33(0)2 40 08 39 10    jrigaud@chu-nantes.fr    Institut de Cancerologie Du Gard - Centre Oncogard Recruiting Nîmes, France, 300029 Contact: Angélique CHAPELLE, Doctor    +33(0)4 30 06 10 14    a.chapelle@oncogard.com    Hopital Saint Louis Recruiting Paris, France, 75010 Contact: Stéphane CULINE, Professor    +33(0)1 42 49 42 47    stephane.culine@aphp.fr    Chu de Rouen Recruiting Rouen, France, 76031 Contact: Christian PFISTER, Professor    +33(0)2 32 88 81 63    christian.pfister@chu-rouen.fr    ICO-René Gauducheau Recruiting saint Herblain, France, 44805 Contact: Emmanuelle BOMPAS, Doctor    +33(0)2 40 67 97 00    emmanuelle.bompas@ico.unicancer.fr    Hopitaux Universitaires de Strasbourg Recruiting Strasbourg, France, 67091 Contact: Philippe BARTHELEMY, Doctor       philippe.barthelemy@chru-strasbourg.fr    Institut Claudius Regaud Recruiting Toulouse, France, 31059 Contact: Loic MOUREY, Doctor    +33(0)5 31 15 51 67    mourey.loic@iuct-oncopole.fr Less <<
NCT03360760 Osteosarcoma of Pelvis Not Applicable Recruiting February 2025 China, Beijing ... More >> Peking University People's Hospital Recruiting Beijing, Beijing, China, 100034 Contact: Jie Xu, M.D.    86 15901040835    xujie_pkuph@sina.com Less <<
NCT00003937 Cardiac Toxicity ... More >> Sarcoma Less << Phase 3 Completed - -
NCT00568607 Lymphoma Phase 2 Unknown December 2010 China, Shanghai ... More >> Fudan University Cancer Hospital Recruiting Shanghai, Shanghai, China, 200032 Contact: Biyun Wang, MD    8613701748410    wangbiyun@msn.com    Sub-Investigator: Biyun Wang, M.D. Less <<
NCT00060944 Liposarcoma L... More >>eiomyosarcoma Less << Phase 2 Completed - -
NCT00933673 Lymphoma Phase 2 Unknown June 2012 China, Shanghai ... More >> Fudan University Cancer Hospital Recruiting Shanghai, Shanghai, China, 200032 Contact: Ye Guo, MD    862164175590    pattrick_guo@msn.com    Principal Investigator: Ye Guo, MD Less <<
NCT03042429 Neuroblastoma Phase 3 Completed - Germany ... More >> University of Cologne Koln, Germany, 50924 Less <<
NCT01453205 Diffuse Large B-Cell Lymphoma Phase 2 Completed - -
NCT03440567 CCND1 Positive ... More >> CD20 Positive Recurrent Diffuse Large B-Cell Lymphoma Recurrent Mantle Cell Lymphoma Refractory Diffuse Large B-Cell Lymphoma Refractory Mantle Cell Lymphoma Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma Less << Phase 1 Recruiting June 8, 2020 United States, California ... More >> City of Hope Medical Center Recruiting Duarte, California, United States, 91010 Contact: Liana Nikolaenko, MD    626-256-4673    lnikolaenko@coh.org    Principal Investigator: Liana Nikolaenko, MD Less <<
NCT01424839 Intracranial Germ Cell Tumors Phase 4 Unknown October 2018 Germany ... More >> University Hospital Muenster Recruiting Muenster, Germany, 48129 Contact: Gabriele Calaminus, MD    +492518358060    gabriele.calaminus@ukmuenster.de    Contact: Carmen Teske    +492518358055    carmen.teske@ukmuenster.de    Principal Investigator: Gabriele Calaminus, MD Less <<
NCT01453205 - Completed - -
NCT00280878 Non-Hodgkin's Lymphoma (CD20+) Phase 2 Completed - Australia, Victoria ... More >> The Alfred Hospital Melbourne, Victoria, Australia, 3004 Frankston Hospital Melbourne, Victoria, Australia Less <<
NCT02106988 Lymphoma Phase 2 Recruiting January 2022 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: MD Anderson Health Information Specialist    877-632-6789 Less <<
NCT00304083 Neurofibromatosis Type 1 ... More >> Sarcoma Less << Phase 2 Completed - United States, Alabama ... More >> UAB Comprehensive Cancer Center Birmingham, Alabama, United States, 35294 United States, California Sarcoma Oncology Center Santa Monica, California, United States, 90403 United States, Illinois Children's Memorial Hospital - Chicago Chicago, Illinois, United States, 60614 United States, Indiana Indiana University Indianapolis, Indiana, United States, 46202-5289 United States, Iowa University of Iowa Hospitals and Clinics Iowa City, Iowa, United States, 52242 United States, Maryland Johns Hopkins Baltimore, Maryland, United States, 21231-2410 Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States, 20892-1182 United States, Michigan University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109-0942 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, North Carolina Carolinas Hematology-Oncology Associates Charlotte, North Carolina, United States, 28203 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229-3039 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Pennsylvania Oncology Hematology Associates Philadelphia, Pennsylvania, United States, 19106 Children's Hospital of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 United States, Texas M. D. Anderson Cancer Center at University of Texas Houston, Texas, United States, 77030-4009 United States, Utah Huntsman Cancer Institute at University of Utah Salt Lake City, Utah, United States, 84112 United States, Washington Seattle Cancer Care Alliance at Washington University Seattle, Washington, United States, 98109 Less <<
NCT00060944 - Completed - -
NCT00304083 - Completed - -
NCT00002822 Lung Cancer Phase 3 Completed - United Kingdom ... More >> Medical Research Council Clinical Trials Unit London, England, United Kingdom, NW1 2DA Less <<
NCT00002466 Kidney Cancer ... More >> Sarcoma Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00334867 Sarcoma Phase 3 Withdrawn(withdrawn) - -
NCT00003284 Lung Cancer Phase 2 Unknown - United States, New York ... More >> Herbert Irving Comprehensive Cancer Center New York, New York, United States, 10032 Less <<
NCT00002854 Cancer Phase 1 Completed - United States, California ... More >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010-3000 Less <<
NCT00003105 Bladder Cancer ... More >> Transitional Cell Cancer of the Renal Pelvis and Ureter Less << Phase 1 Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00691236 Osteosarcoma Phase 2 Phase 3 Unknown August 2013 India ... More >> Tata Memorial Hospital Recruiting Mumbai, Maharashtra, India, 400012 Principal Investigator: Manish G Agarwal, M.S(Orth) Less <<
NCT01481272 Diffuse Large B Cell Lymphoma Phase 2 Completed - Poland ... More >> Dolnośląskie Centrum Transplantacji Komórkowych Wrocław, Dolnośląskie, Poland, 53-439 Instytut Hematologii i Transfuzjologii Warszawa, Mazowieckie, Poland, 02-776 Centrum Onkologii - Istytut im. M.Sklodowskiej-Curie Warszawa, Mazowieckie, Poland, 02-781 Szpital Specjalistyczny w Brzozowie Podkarpacki Ośrodek Onkologiczny im. ks. Bronisława Markiewicza Brzozów, Podkarpackie, Poland, 16-200 Uniwersyteckie Cenrum Medyczne Gdańsk, Pomorskie, Poland, 80-952 Szpital Morski im. PCK Oddz. Onkologii i Radioterapii Gdynia, Pomorskie, Poland, 81-519 Klinika Transplantacji Szpiku i Onkohematologii; Centrum Onkologii Instytut im. M.Sklodowskiej-Curie, Oddz. w Gliwicach Gliwice, Slaskie, Poland, 44-101 Oddz. Hematologii, Samodzielny Publiczny ZOZ MSW z Warminsko-Mazurskim Centrum Onkologii w Olsztynie Olsztyn, Warminsko-Mazurskie, Poland, 10-228 Less <<
NCT00003052 Sarcoma Phase 3 Completed - Germany ... More >> Robert Roessle Comprehensive Cancer Center at University of Berlin - Charite Campus Buch Berlin, Germany, D-13122 Universitaetsklinikum Essen Essen, Germany, D-45122 Universitaetsklinikum Hamburg-Eppendorf Hamburg, Germany, D-20246 Klinikum der Universitaet Muenchen - Grosshadern Campus Munich, Germany, D-81377 Less <<
NCT00588094 Lymphoma B-ce... More >>ll Non-Hodgkin's Lymphoma Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00588094 - Completed - -
NCT00541411 Ewing's Sarcoma Not Applicable Unknown June 2013 -
NCT00162721 Uterine Sarcoma Phase 3 Unknown - France ... More >> Institut Gustave Roussy Recruiting Villejuif, France, 94800 Contact: Patricia Pautier, Dr    33 1 42 11 4340    pautier@igr.fr Less <<
NCT01299506 - Completed - Netherlands ... More >> NKI Amsterdam Amsterdam, Netherlands, 1066 CX UMC Groningen Groningen, Netherlands, 9700 RB Leiden University Leiden, Netherlands, 2300 RC Nijmegen UMCN Nijmegen, Netherlands, 6500 HB Erasmus MC Rotterdam Rotterdam, Netherlands, 3015E Less <<
NCT02393157 Non-Hodgkin Lymphoma ... More >> Burkitt Lymphoma Diffuse Large B-Cell Lymphoma Primary Mediastinal B-cell Lymphoma CD20+ Lymphoblastic Lymphoma Follicular Lymphoma, Grade III Less << Phase 2 Recruiting June 2019 United States, New York ... More >> New York Medical College Recruiting Valhalla, New York, United States, 10595 Contact: Jessica Hochberg, MD    914-594-2150    jessica_hochberg@nymc.edu    Contact: Mitchell Cairo, MD    914-594-2150    mitchell_cairo@nymc.edu Less <<
NCT00004887 Lung Cancer Phase 3 Unknown - United Kingdom ... More >> Christie Hospital N.H.S. Trust Manchester, England, United Kingdom, M20 4BX Less <<
NCT03071822 Peripheral T Cell Lymphoma Phase 4 Recruiting February 28, 2022 Hong Kong ... More >> The University of Hong Kong Recruiting Hong Kong, Hong Kong Contact: King Hei Lu, MMedSc    852-22554361 ext 1654    khlu@hku.hk    Contact: Zoe Chan, BNs    852-22551654    zoechan1@hku.hk    Principal Investigator: Yok Lam Kwong, MD(HK)          Sub-Investigator: Thomas Chan, MBBS(HK) Less <<
NCT02628405 CD20 Positive ... More >> Recurrent B-Cell Non-Hodgkin Lymphoma Recurrent Diffuse Large B-Cell Lymphoma Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma Recurrent Transformed Non-Hodgkin Lymphoma Refractory B-Cell Non-Hodgkin Lymphoma Refractory Diffuse Large B-Cell Lymphoma Refractory Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma Refractory Transformed Non-Hodgkin Lymphoma Less << Phase 1 Phase 2 Recruiting January 20, 2023 United States, Florida ... More >> Mayo Clinic in Florida Recruiting Jacksonville, Florida, United States, 32224-9980 Contact: Kathleen M. Burke    904-953-2000    Burke.Kathleen@mayo.edu    Principal Investigator: Han W. Tun          United States, Illinois Illinois CancerCare-Peoria Withdrawn Peoria, Illinois, United States, 61615 Carle Cancer Center NCI Community Oncology Research Program Recruiting Urbana, Illinois, United States, 61801 Contact: Pauline Mbuvi    217-383-4085    Pauline.Mbuvi@Carle.com    Principal Investigator: Priyank P. Patel          United States, Iowa University of Iowa/Holden Comprehensive Cancer Center Recruiting Iowa City, Iowa, United States, 52242 Contact: Susan B. Butcher    319-467-5827    susan-butcher@uiowa.edu    Principal Investigator: Umar Farooq          United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Mayo Clinic Clinical Trials Office    855-776-0015       Principal Investigator: Grzegorz S. Nowakowski          Coborn Cancer Center at Saint Cloud Hospital Recruiting Saint Cloud, Minnesota, United States, 56303 Contact: Stacy St. Onge    320-229-4907    stacy.stonge@centracare.com    Principal Investigator: Donald J. Jurgens          Metro Minnesota Community Oncology Research Consortium Recruiting Saint Louis Park, Minnesota, United States, 55416 Contact: Elizabeth J. Wagner    952-992-1555    Elizabeth.wagner@parknicollet.com    Principal Investigator: Daniel M. Anderson          United States, Nebraska University of Nebraska Medical Center Withdrawn Omaha, Nebraska, United States, 68198 United States, New Hampshire Dartmouth Hitchcock Medical Center Recruiting Lebanon, New Hampshire, United States, 03756 Contact: Julie Gurnsey    603-653-3640    Julie.d.gurnsey@hitchcock.org    Principal Investigator: Frederick Lansigan          United States, New Jersey Hackensack University Medical Center Recruiting Hackensack, New Jersey, United States, 07601 Contact: Kara M. Yannotti    551-996-5900    Kara.Yannotti@HackensackMeridian.org    Principal Investigator: Tatyana A. Feldman          United States, New York State University of New York Upstate Medical University Recruiting Syracuse, New York, United States, 13210 Contact: Joanne M. Chilton    315-464-8240    chiltonj@upstate.edu    Principal Investigator: Teresa C. Gentile          United States, Pennsylvania Geisinger Medical Center Withdrawn Danville, Pennsylvania, United States, 17822 United States, South Dakota Rapid City Regional Hospital Completed Rapid City, South Dakota, United States, 57701 United States, Wisconsin Marshfield Clinic Recruiting Marshfield, Wisconsin, United States, 54449 Contact: Sheryl L. Mandel    715-389-4457    Mandel.Sheryl@mcrf.mfldclin.edu    Principal Investigator: Ali W. Bseiso Less <<
NCT02531841 Diffuse Large B-cell-lymphoma Phase 3 Recruiting December 2019 Germany ... More >> University Hospital Freiburg - Department for Hematology, Oncology and Stem cell Transplantion Recruiting Freiburg, Baden-Wuerttemberg, Germany, 79106 Contact: Juergen Finke, PhD    +49761270 ext 34080    juergen.finke@uniklinik-freiburg.de    Contact: Elisabeth Schorb, PhD    +49761270 ext 33210    elisabeth.schorb@uniklinik-freiburg.de    Klinikum Stuttgart, Clinic of Hematology, Oncology and Palliative Care, Stuttgart Cancer Center / Tumor Center Eva Mayr-Stihl Recruiting Stuttgart, Baden-Wuerttemberg, Germany, 70174 Contact: Gerald Illerhaus, PhD    +49 711 278 ext 30400    G.Illerhaus@klinikum-stuttgart.de    Contact: Kristina Mikesch, PhD    +49 711 278 ext 30403    k.mikesch@klinikum-stuttgart.de Less <<
NCT00421135 Advanced Cancer PHASE1 COMPLETED 2025-10-07 Santa Monica, California, Unit... More >>ed States|Detroit, Michigan, United States Less <<
NCT00002804 Sarcoma Phase 2 Completed - United States, Kansas ... More >> Via Christi Regional Medical Center Wichita, Kansas, United States, 67214 United States, Louisiana MBCCOP - LSU Medical Center New Orleans, Louisiana, United States, 70112 United States, Tennessee Saint Jude Children's Research Hospital Memphis, Tennessee, United States, 38105-2794 United States, Texas Medical City Dallas Hospital Dallas, Texas, United States, 75230 San Antonio Military Pediatric Cancer and Blood Disorders Center Lackland Air Force Base, Texas, United States, 78236-5300 University of Texas Health Science Center at San Antonio San Antonio, Texas, United States, 78284-7811 United States, Virginia Cancer Center, University of Virginia HSC Charlottesville, Virginia, United States, 22908 Puerto Rico University of Puerto Rico School of Medicine Medical Sciences Campus San Juan, Puerto Rico, 00936-5067 Switzerland Clinique de Pediatrie Geneva, Switzerland, 1211 Less <<
NCT03458260 Aggressive Non-Hodgkin Lymphom... More >>a Less << Phase 2 Recruiting March 2025 France ... More >> CH d'Avignon Recruiting Avignon, France Contact: Borhane Slama          Hôpital Haut-Lévèque Recruiting Bordeaux, France Contact: Krimo Bouabdallah          CHRU de Lille Recruiting Lille, France Contact: Franck Morschhauser          CHU Lyon Sud Recruiting Lyon, France Contact: Gilles Salles          CHU de la Conception Recruiting Marseille, France Contact: Vadim Ivanov          Centre Lacassagne Recruiting Nice, France Contact: Antoine Thyss          Hopital La Pitié Salpétriere Recruiting Paris, France Contact: Sylvain Choquet          Hôpital St louis Recruiting Paris, France Contact: Sandy Amorin          CHU de Poitiers Recruiting Poitiers, France Contact: Vincent Delwail          CH de Cornouaille Recruiting Quimper, France Contact: Ronan Le Calloch          CHU de Rouen Recruiting Rouen, France Contact: Hervé Tilly          CHU de Strasbourg Recruiting Strasbourg, France Contact: Luc-Matthieu Fornecker          CHU de Tours Recruiting Tours, France Contact: Emmanuel Gyan Less <<
NCT00470223 Sarcoma Phase 3 Terminated(IDMC decision upon ... More >>interim efficacy analysis) Less << April 2025 France ... More >> Centre Paul Papin Angers, France, 49036 Institut Gustave Roussy Angers, France, 49036 Centre Hospitalier Regional de Besancon - Hopital Jean Minjoz Besancon, France, 25030 CHR de Besancon - Hopital Saint-Jacques Besancon, France, 25030 Institut Bergonie Bordeaux, France, 33076 CHU Hopital A. Morvan Brest, France, 29609 CHU de Caen Caen, France, 14033 Centre Regional Francois Baclesse Caen, France, 14076 CHR Clermont Ferrand, Hotel Dieu Clermont-Ferrand, France, 63003 Centre Jean Perrin Clermont-Ferrand, France, 63011 Centre de Lutte Contre le Cancer Georges-Francois Leclerc Dijon, France, 21079 Centre Hospitalier Universitaire de Dijon Dijon, France, 21079 CHU de Grenoble - Hopital Michallon Grenoble, France, 38043 Centre Oscar Lambret Lille, France, 59020 Centre Leon Berard Lyon, France, 69373 Hopital Edouard Herriot - Lyon Lyon, France, 69437 Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes Marseille, France, 13273 CHU de la Timone Marseille, France, 13385 Hopital d'Enfants de la Timone Marseille, France, 13385 CHU Nord Marseille, France, 13915 Hopital Arnaud de Villeneuve Montpellier, France, 34295 Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle Montpellier, France, 34298 Centre Regional Rene Gauducheau Nantes-Saint Herblain, France, 44805 Centre Antoine Lacassagne Nice, France, 06189 Hopital de l'Archet CHU de Nice Nice, France, F-06202 Institut Curie Hopital Paris, France, 75248 Hopital Jean Bernard Poitiers, France, 86021 Centre Eugene Marquis Rennes, France, 35042 Hopital Charles Nicolle Rouen, France, 76031 Centre Henri Becquerel Rouen, France, 76038 Institut de Cancerologie de la Loire Saint Priest en Jarez, France, 42270 Hopitaux Universitaire de Strasbourg Strasbourg, France, 67091 Hopital Universitaire Hautepierre Strasbourg, France, 67098 Hopital des Enfants Toulouse, France, 31059 C.H. Bastien de Clocheville Tours, France, 3700 CHRU de Tours - Hopital Trousseau Tours, France, 37044 Centre Alexis Vautrin Vandoeuvre-les-Nancy, France, 54511 Less <<
NCT00470366 Brain and Central Nervous Syst... More >>em Tumors Extragonadal Germ Cell Tumor Ovarian Cancer Teratoma Testicular Germ Cell Tumor Less << Phase 2 Completed - United States, California ... More >> USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States, 90089-9181 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00002982 Lymphoma Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT01226849 Diffuse Large B-Cell Lymphoma Phase 1 Completed - Singapore ... More >> Singapore General Hospital Singapore, Singapore, 169608 Less <<
NCT03206671 Mature B-cell Non-Hodgkin Lymp... More >>homa Less << Phase 3 Recruiting August 2024 -
NCT00003776 Sarcoma Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00003240 Lung Cancer Phase 3 Unknown - United Kingdom ... More >> Middlesex Hospital- Meyerstein Institute London, England, United Kingdom, WIT 3AA Less <<
NCT00102752 Neoplasms Pan... More >>creatic Neoplasms Less << Phase 1 Phase 2 Completed - United States, Arizona ... More >> Arizona Cancer Center Tucson, Arizona, United States, 85724 United States, Indiana Indiana Cancer Center Indianapolis, Indiana, United States, 46202 United States, Kentucky Norton Healthcare Cancer Center Louisville, Kentucky, United States, 40202 Brazil Hospital de Doenças Cardiovasculares - Biocor Nova Lima, BH, Brazil, 34000-000 Hospital Mãe de Deus Porto Alegre, RS, Brazil, 90880-480 Hospital Nossa Senhora da Conceição Porto Alegre, RS, Brazil, 91350-200 Fundação Pio XII - Hospital de Câncer de Barretos Barretos, SP, Brazil, 14784-400 Universidade Federal de São Paulo - Hospital São Paulo São Paulo, SP, Brazil, 04023-900 Hospital Israelita Albert Einstein São Paulo, SP, Brazil, 05651-901 Less <<
NCT00662233 Ovarian Cancer ... More >> Sarcoma Less << Early Phase 1 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00003852 Childhood Germ Cell Tumor ... More >> Extragonadal Germ Cell Tumor Ovarian Cancer Testicular Germ Cell Tumor Less << Phase 2 Terminated(lack of patient inc... More >>lusion) Less << - France ... More >> Centre Paul Papin Angers, France, 49036 CHR de Besancon - Hopital Jean Minjoz Besancon, France, 25030 Institut Bergonie Bordeaux, France, 33076 Centre Regional Francois Baclesse Caen, France, 14076 Centre Jean Perrin Clermont-Ferrand, France, 63011 Centre de Lute Contre le Cancer,Georges-Francois Leclerc Dijon, France, 21079 CHR de Grenoble - La Tronche Grenoble, France, 38043 Clinique Saint Michel La Rochelle, France, 17000 Centre Leon Berard Lyon, France, 69373 Institut J. Paoli and I. Calmettes Marseille, France, 13273 Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle Montpellier, France, 34298 Centre Antoine Lacassagne Nice, France, 06189 Hopital d'Instruction des Armees du Val de Grace Paris, France Institut Jean Godinot Reims, France, 51056 Centre Henri Becquerel Rouen, France, 76038 Centre Rene Huguenin Saint Cloud, France, 92211 Hopitaux Universitaire de Strasbourg Strasbourg, France, 67091 Institut Gustave Roussy Villejuif, France, F-94805 Less <<
NCT03206450 - Recruiting September 5, 2021 -
NCT01362530 Chemotherapy Induced Nausea an... More >>d Vomiting Less << Phase 3 Completed - -
NCT01362530 - Completed - -
NCT00787722 Devic's Disease Phase 1 Phase 2 Active, not recruiting January 2019 United States, Illinois ... More >> Northwestern University, Feinberg School of Medicine Chicago, Illinois, United States, 60611 Less <<
NCT03593902 Systemic Sclerosis ... More >> Scleroderma Less << Phase 2 Phase 3 Recruiting January 2026 United States, Illinois ... More >> Northwestern University, Feinberg School of Medicine Recruiting Chicago, Illinois, United States, 60611 Contact: Kathleen Quigley    312-695-4960    k-quigley@northwestern.edu    Principal Investigator: Richard Burt, MD          Northwestern University Recruiting Chicago, Illinois, United States, 60611 Contact: Kathleen Quigley, RN    312-695-8192    kathleen.quigley@nm.org    Principal Investigator: Richard Burt, MD Less <<
NCT02288741 Multiple Myeloma Phase 3 Completed - -
NCT02842931 Diffuse Large B-Cell Lymphoma Phase 3 Recruiting February 2023 Russian Federation ... More >> National Research Center for Hematology Recruiting Moscow, Russian Federation, 125167 Contact: Aminat U Magomedova, MD, PhD    495-613-2446 ext 007    maminat@mail.ru    Contact: Sergay K Kravchenko, MD, PhD    495-613-2446 ext 007    krav-hsc-ramn@mail.ru    Principal Investigator: Aminat U Magomedova, MD, PhD          Sub-Investigator: Sergey K Kravchenko, MD, PhD          Sub-Investigator: Anna E Misurina, MD, PhD Less <<
NCT02316613 - Completed - -
NCT03479918 Lymphoma, High-Grade Phase 3 Recruiting March 15, 2024 Russian Federation ... More >> National Research Center for Hematology Recruiting Moscow, Russian Federation, 125167 Contact: Elena Parovichnikova, MD, PhD       director@blood.ru    Sub-Investigator: Sergey Kravchenko, MD, PhD          Sub-Investigator: Anna Misyurina, MD, PhD          Sub-Investigator: Aminat Magomedova, MD, PhD          Sub-Investigator: Sergey Kulikov, PhD          Sub-Investigator: Alla Kovrigina, PhD          Sub-Investigator: Tatiana Obukhova, PhD Less <<
NCT00617890 Osteosarcoma ... More >>Sarcoma, Ewing's Peripheral Neuroectodermal Tumor Less << Phase 2 Terminated(The study was prema... More >>turely terminated for strategic reasons, not for a safety concern.) Less << - -
NCT02316613 - Completed - France ... More >> Neuilly-sur-seine, France, 92521 Less <<
NCT01576692 Neuroblastoma Phase 1 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT03382158 - Recruiting December 6, 2026 United States, Minnesota ... More >> Children;s Minnesota Recruiting Minneapolis, Minnesota, United States, 55404 Contact: Gretchen Williams, BS    612-813-7115    gretchen.williams@childrensmn.org Less <<
NCT00617890 - Terminated(The study was prema... More >>turely terminated for strategic reasons, not for a safety concern.) Less << - -
NCT01833546 Solid Tumor P... More >>ancreatic Cancer Less << Phase 1 Completed - Japan ... More >> Research Site Kashiwa, Japan Research Site Tokyo, Japan Less <<
NCT03034850 - Completed - -
NCT00554164 Lymphoma, High-grade Phase 3 Completed - Germany ... More >> Department of Hematology, University Hospital Essen Essen, Germany, 45122 Less <<
NCT00025064 Lymphoma Phase 2 Unknown - Ireland ... More >> Our Lady's Hospital for Sick Children Dublin, Ireland, 12 United Kingdom Birmingham Children's Hospital Birmingham, England, United Kingdom, B4 6NH Bristol Royal Hospital for Children Bristol, England, United Kingdom, BS2 8BJ Addenbrooke's Hospital at Cambridge University Hospitals NHS Foundation Trust Cambridge, England, United Kingdom, CB2 2QQ Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Leicester Royal Infirmary Leicester, England, United Kingdom, LE1 5WW Royal Liverpool Children's Hospital, Alder Hey Liverpool, England, United Kingdom, L12 2AP Saint Bartholomew's Hospital London, England, United Kingdom, EC1A 7BE Great Ormond Street Hospital for Children NHS Trust London, England, United Kingdom, WC1N 3JH Meyerstein Institute of Oncology at University College of London Hospitals London, England, United Kingdom, WIT 3AA Central Manchester and Manchester Children's University Hospitals NHS Trust Manchester, England, United Kingdom, M27 4HA Newcastle Upon Tyne Hospitals NHS Trust Newcastle-Upon-Tyne, England, United Kingdom, NE7 7DN Queen's Medical Centre Nottingham, England, United Kingdom, NG7 2UH Oxford Radcliffe Hospital Oxford, England, United Kingdom, 0X3 9DU Children's Hospital - Sheffield Sheffield, England, United Kingdom, S10 2TH Southampton General Hospital Southampton, England, United Kingdom, SO16 6YD Royal Marsden NHS Foundation Trust - Surrey Sutton, England, United Kingdom, SM2 5PT Royal Belfast Hospital for Sick Children Belfast, Northern Ireland, United Kingdom, BT12 6BE Aberdeen Royal Infirmary Aberdeen, Scotland, United Kingdom, AB25 2ZN Royal Hospital for Sick Children Edinburgh, Scotland, United Kingdom, EH9 1LF Royal Hospital for Sick Children Glasgow, Scotland, United Kingdom, G3 8SJ Less <<
NCT00012051 Lymphoma Phase 3 Completed - Belgium ... More >> U.Z. Gasthuisberg Leuven, Belgium, B-3000 Netherlands HagaZiekenhuis - Locatie Leyenburg 's-Gravenhage, Netherlands, 2545 CH Jeroen Bosch Ziekenhuis 's-Hertogenbosch, Netherlands, 5211 NL Meander Medisch Centrum Amersfoort, Netherlands, 3816 CP Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital Amsterdam, Netherlands, 1066 BE Vrije Universiteit Medisch Centrum Amsterdam, Netherlands, 1081HV Academisch Medisch Centrum at University of Amsterdam Amsterdam, Netherlands, 1105 AZ Medisch Spectrum Twente Enschede, Netherlands, 7500 KA University Medical Center Groningen Groningen, Netherlands, 9713 EZ Medisch Centrum Leeuwarden - Zuid Leeuwarden, Netherlands, 8934 AD Leiden University Medical Center Leiden, Netherlands, 2300 CA Academisch Ziekenhuis Maastricht Maastricht, Netherlands, 6202 AZ Sint Antonius Ziekenhuis Nieuwegein, Netherlands, 3435 CM Universitair Medisch Centrum St. Radboud - Nijmegen Nijmegen, Netherlands, NL-6500 HB Daniel Den Hoed Cancer Center at Erasmus Medical Center Rotterdam, Netherlands, 3008 AE University Medical Center Utrecht Utrecht, Netherlands, 3584 CX Isala Klinieken - locatie Sophia Zwolle, Netherlands, 8000 GK Less <<
NCT00002531 Leukemia Phase 2 Unknown - Germany ... More >> Klinikum der J.W. Goethe Universitaet Frankfurt, Germany, D-60590 Less <<
NCT00018954 Leukemia Lymp... More >>homa Less << Phase 2 Completed - United States, Maryland ... More >> Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States, 20892-1182 Egypt National Cancer Institute of Egypt Cairo, Egypt India Kidwai Memorial Institute of Oncology Bangalore, India, 560029 Cancer Institute (W.I.A.) Madras, India, 600020 Tata Memorial Centre Mumbai, India, 400012 Less <<
NCT00002532 Leukemia Phase 2 Unknown - Germany ... More >> Medizinische Hochschule Hannover Hannover, Germany, D-30625 Less <<
NCT01833546 - Completed - -
NCT00003086 Breast Cancer Phase 1 Phase 2 Unknown - United States, Louisiana ... More >> Louisiana State University School of Medicine Shreveport, Louisiana, United States, 71130-3932 Less <<
NCT00002865 Leukemia Phase 2 Completed - United States, North Carolina ... More >> Comprehensive Cancer Center of Wake Forest University Baptist Medical Center Winston-Salem, North Carolina, United States, 27157-1082 Less <<
NCT00040690 Leukemia Lymp... More >>homa Less << Phase 2 Completed - United Kingdom ... More >> Medical Research Council Clinical Trials Unit London, England, United Kingdom, NW1 2DA Less <<
NCT00017368 Neuroblastoma Phase 2 Completed - United States, Georgia ... More >> AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Scottish RiteCampus Atlanta, Georgia, United States, 30342 United States, Massachusetts Floating Hospital for Children Boston, Massachusetts, United States, 02111 Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Oregon CCOP - Columbia River Oncology Program Portland, Oregon, United States, 97225 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 CCOP - Scott and White Hospital Temple, Texas, United States, 76508 United States, Wisconsin CCOP - Marshfield Clinic Research Foundation Marshfield, Wisconsin, United States, 54449 Australia, Western Australia Princess Margaret Hospital for Children Perth, Western Australia, Australia, 6001 Less <<
NCT00012311 Breast Cancer Phase 2 Unknown - United States, New York ... More >> Herbert Irving Comprehensive Cancer Center New York, New York, United States, 10032 Less <<
NCT00006455 Lymphoma Phase 3 Unknown - Austria ... More >> St. Anna Children's Hospital Vienna, Austria, A-1090 Belgium U.Z. Gasthuisberg Leuven, Belgium, B-3000 France Institut Gustave Roussy Villejuif, France, F-94805 Germany Kinderklinik Giessen, Germany, D-35385 Italy Azienda Ospedaliera di Padova Padova, Italy, 35128 Netherlands Dutch Childhood Leukemia Study Group Den Haag, Netherlands, 2504 AM Spain Hospital Clinico Universitario de Valencia Valencia, Spain, 46010 Sweden Karolinska University Hospital - Huddinge Stockholm, Sweden, S-171 76 Switzerland University Children's Hospital Zurich, Switzerland, CH-8032 United Kingdom Addenbrooke's Hospital Cambridge, England, United Kingdom, CB2 2QQ Less <<
NCT00199056 Adult Acute Lymphocytic Leukem... More >>ia Less << Phase 4 Completed - Germany ... More >> University Hospital, Medical Dept. II Frankfurt, Germany, 60590 Less <<
NCT00003159 Lung Cancer Phase 3 Completed - United Kingdom ... More >> Medical Research Council Clinical Trials Unit London, England, United Kingdom, NW1 2DA Royal Marsden NHS Foundation Trust - Surrey Sutton, England, United Kingdom, SM2 5PT Less <<
NCT00017225 Neuroblastoma Phase 2 Completed - -
NCT00199082 Burkitt's Lymphoma ... More >> Burkitt's Leukemia Mediastinal Neoplasms Lymphoblastic Lymphoma Large Cell Anaplastic Lymphoma Less << Phase 4 Completed - Germany ... More >> University Hospital, Medical Dept. II Frankfurt, Germany, 60590 Less <<
NCT00317408 Lymphoma Not Applicable Unknown - -
NCT00025441 Ovarian Cancer ... More >> Sarcoma Small Intestine Cancer Less << Phase 2 Completed - France ... More >> Centre Leon Berard Lyon, France, 69373 Ireland Our Lady's Hospital for Sick Children Crumlin, Ireland, 12 United Kingdom Birmingham Children's Hospital Birmingham, England, United Kingdom, B4 6NH Bristol Royal Hospital for Children Bristol, England, United Kingdom, BS2 8BJ Addenbrooke's Hospital at Cambridge University Hospitals NHS Foundation Trust Cambridge, England, United Kingdom, CB2 2QQ Leicester Royal Infirmary Leicester, England, United Kingdom, LE1 5WW Royal Liverpool Children's Hospital, Alder Hey Liverpool, England, United Kingdom, L12 2AP Saint Bartholomew's Hospital London, England, United Kingdom, EC1A 7BE Leeds Cancer Centre at St. James's University Hospital London, England, United Kingdom, W6 8RF Great Ormond Street Hospital for Children NHS Trust London, England, United Kingdom, WC1N 3JH Meyerstein Institute of Oncology at University College of London Hospitals London, England, United Kingdom, WIT 3AA Central Manchester and Manchester Children's University Hospitals NHS Trust Manchester, England, United Kingdom, M27 4HA Newcastle Upon Tyne Hospitals NHS Trust Newcastle-Upon-Tyne, England, United Kingdom, NE7 7DN Queen's Medical Centre Nottingham, England, United Kingdom, NG7 2UH Oxford Radcliffe Hospital Oxford, England, United Kingdom, 0X3 9DU Children's Hospital - Sheffield Sheffield, England, United Kingdom, S10 2TH Southampton General Hospital Southampton, England, United Kingdom, SO16 6YD Royal Marsden NHS Foundation Trust - Surrey Sutton, England, United Kingdom, SM2 5PT Royal Belfast Hospital for Sick Children Belfast, Northern Ireland, United Kingdom, BT12 6BE Aberdeen Royal Infirmary Aberdeen, Scotland, United Kingdom, AB25 2ZN Royal Hospital for Sick Children Edinburgh, Scotland, United Kingdom Royal Hospital for Sick Children Glasgow, Scotland, United Kingdom, G3 8SJ Less <<
NCT00002898 Childhood Malignant Fibrous Hi... More >>stiocytoma of Bone Sarcoma Less << Phase 3 Completed - United Kingdom ... More >> Institute of Child Health Bristol, England, United Kingdom, BS2 8AE Less <<
NCT00003541 Lymphoma Phase 1 Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00430118 Leukemia Phase 3 Completed - -
NCT00199069 Adult Acute Lymphocytic Leukem... More >>ia Less << Phase 4 Completed - Germany ... More >> University Hospital, Medical Dept. II Frankfurt, Germany Less <<
NCT00002643 Neutropenia S... More >>arcoma Less << Phase 2 Completed - -
NCT00002494 Leukemia Lymp... More >>homa Less << Phase 2 Completed - -
NCT00165139 Neuroblastoma ... More >> Ewings Sarcoma Non-rhabdomyosarcoma Soft Tissue Sarcoma Less << Phase 2 Completed - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00002802 Neuroblastoma Phase 3 Completed - Germany ... More >> University of Cologne Frechen, Germany, DOH-5-0226 Less <<
NCT00199095 Adult Acute Lymphocytic Leukem... More >>ia Less << Phase 4 Completed - Germany ... More >> University Hospital, Medical Dept. II Frankfurt, Germany, 60590 Less <<
NCT00077285 Sarcoma Phase 2 Active, not recruiting October 2019 United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00410631 Neuroblastoma Phase 3 Unknown - -
NCT00764907 Leukemia Phase 3 Unknown - Czech Republic ... More >> University Hospital Motol Recruiting Prague, Czech Republic, 150 06 Contact: Jan Stary, MD    420-2-2443-6401    jan.stary@lfmotol.cuni.cz Less <<
NCT00920153 Lymphoma Phase 3 Terminated(Other new drugs) - France ... More >> FILO French Innovative Leukemia Organization Tours Cedex, France, 37044 Less <<
NCT00003209 Cervical Cancer Phase 3 Completed - United Kingdom ... More >> Derbyshire Royal Infirmary Derby, England, United Kingdom, DE1 2QY Beatson Oncology Centre Glasgow, Scotland, United Kingdom, G11 6NT Less <<
NCT00002516 Sarcoma Phase 3 Unknown - United Kingdom ... More >> Royal Victoria Infirmary Newcastle-upon-Tyne, England, United Kingdom, NE1 4LP Less <<
NCT00669812 Lymphoma Smal... More >>l Intestine Cancer Less << Phase 2 Unknown - United Kingdom ... More >> Sir James Spence Institute of Child Health at Royal Victoria Infirmary Recruiting Newcastle-Upon-Tyne, England, United Kingdom, NE1 4LP Contact: Anne Lennard    44-191-282-4743    a.l.lennard@ncl.ac.uk Less <<
NCT01117441 Leukemia Phase 3 Active, not recruiting December 2021 -
NCT00974792 Lymphoma Phase 2 Unknown - United Kingdom ... More >> Nottingham City Hospital Recruiting Nottingham, England, United Kingdom, NG5 1PB Contact: A. McMillan    44-115-969-1169 Less <<
NCT00526318 Neuroblastoma Not Applicable Unknown - -
NCT01156883 Leukemia Not Applicable Completed - Italy ... More >> Complesso Ospedaliero S. Giovanni Addolorata Roma, (rm), Italy, 00184 Azienda Ospedaliera - Nuovo Ospedale "Torrette" Ancona, Italy USL 8 - Ospedale S.Donato Arezzo, Italy Dipartimento Area Medica - Presidio Ospedaliero "C. e G.Mazzoni" Ascoli, Italy Az.Ospedaliera S.G.Moscati Avellino, Italy UO Ematologia con trapianto- AOU Policlinico Consorziale di Bari Bari, Italy Istituto di Ematologia "Lorenzo e A. Seragnoli" - Università degli Studi di Bologna - Policlinico S. Orsola - Malpighi Bologna, Italy Divisione di Ematologia Ospedale A. Perrino Brindisi, Italy Università di Catania - Cattedra di Ematologia - Ospedale "Ferrarotto" Catania, Italy Azienda Ospedaliera Pugliese Ciaccio - Presidio Ospedaliero A.Pugliese - Unità Operativa di Ematologia Catanzaro, Italy Sezione di Ematologia e Fisiopatologia delle Emostasi - Azienda Ospedaliera - Arcispedale S. Anna Ferrara, Italy Divisione Ematologia 1 - Azienda Ospedaliera Universitaria "San Martino" Genova, Italy ASL Le/1 P.O. Vito Fazzi - U.O. di Ematologia ed UTIE Lecce, Italy Divisione di Ematologia - Azienda Ospedaliera Ospedali Riuniti "Papardo Piemonte" Messina, Italy Ospedale Niguarda " Ca Granda" Milano, Italy Centro Oncologico Modenese - Dipartimento di Oncoematologia Modena, Italy Azienda Ospedaliera di Rilievo Nazionale "A. Cardarelli" Napoli, Italy UOSC di Ematologia Oncologica - Istituto Nazionale Tumori "Fondazione Senatore Giovanni Pascale" Napoli, Italy zienda Ospedaliera Universitaria - Università degli Studi di Napoli "Federico II" - Facoltà di Medicina e Chirurgia Napoli, Italy Inferiore U.O. Medicina Interna Ematologia ed Oncologia P.O. Umberto I Nocera Inferiore, Italy S.C.D.U. Ematologia - DIMECS e Dipartimento Oncologico - Università del Piemonte Orientale Amedeo Avogadro Novara, Italy Divisione di Ematologia con trapianto di midollo - A.U. Policlinico "Paolo Giaccone" Palermo, Italy Ospedali Riuniti "Villa Sofia-Cervello" Palermo, Italy Cattedra di Ematologia CTMO Università degli Studi di Parma Parma, Italy S.C. Ematologia - Fondazione IRCCS Policlinico S. Matteo Pavia, Italy U.O. Ematologia Clinica - Azienda USL di Pescara Pescara, Italy Università di Pisa - Azienda Ospedaliera Pisana - Dipartimento di Oncologia, dei Trapianti e delle nuove Tecnologie in Medicina - Divisione di Ematologia Pisa, Italy Dipartimento Oncologico - Ospedale S.Maria delle Croci Ravenna, Italy Dipartimento Emato-Oncologia A.O."Bianchi-Melacrino-Morelli" Reggio Calabria, Italy Unità Operativa Complessa di Ematologia - Arcispedale S. Maria Nuova Reggio Emilia, Italy Az. Ospedaliera "Sant' Andrea"-Università la Sapienza Seconda Facoltà di Medicina e Chirurgia Roma, Italy Divisione di Ematologia - Ospedale S. Camillo Divisione di Ematologia - Ospedale S. Camillo Roma, Italy Divisione Ematologia - Università Campus Bio-Medico Roma, Italy S.C. di Ematologia e Trapianti - I.F.O. Istituto Nazionale Tumori Regina Elena Roma, Italy U.O.C. Ematologia - Ospedale S.Eugenio Roma, Italy Università Cattolica del Sacro Cuore - Policlinico A. Gemelli Roma, Italy Università degli Studi - Policlinico di Tor Vergata Roma, Italy Universita Degli Studi "La Sapeinza" Rome, Italy, 00161 Istituto di Ematologia - IRCCS Ospedale Casa Sollievo della Sofferenza S. G. Rotondo, Italy Serv. di Ematologia Ist. di Ematologia ed Endocrinologia Sassari, Italy Struttura Complessa Ematologia - Azienda Sanitaria Locale BAT1- Presidio Ospedaliero Bisceglie-Trani Trani, Italy Clinica Ematologica - Policlinico Universitario Udine, Italy Università degli Studi di Verona - A. O. - Istituti Ospitalieri di Verona- Div. di Ematologia - Policlinico G.B. Rossi Verona, Italy Less <<
NCT00011921 Lung Cancer Phase 3 Unknown - Switzerland ... More >> Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 Less <<
NCT01954992 Metastatic Pancreatic Adenocar... More >>cinoma Less << Phase 3 Recruiting September 2019 -
NCT00574496 Lymphoma Phase 2 Active, not recruiting November 2019 United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00379457 Sarcoma Phase 3 Unknown - Austria ... More >> St. Anna Children's Hospital Recruiting Vienna, Austria, A-1090 Contact: Ruth Ladenstein, MD    43-1-404-700       Belgium Hopital Universitaire Des Enfants Reine Fabiola Recruiting Brussels, Belgium, 1020 Contact: Christine Devalck, MD    32-2-477-2678       Denmark Rigshospitalet - Copenhagen University Hospital Recruiting Copenhagen, Denmark, 2100 Contact: Catherine Rechnitzer, MD, PhD    45-3545-1368    rechnitzer@rh.dk    Ireland Our Lady's Hospital for Sick Children Crumlin Recruiting Dublin, Ireland, 12 Contact: Fin Breatnach, MD, FRCPE    353-1-409-6659    fin.breatnach@olhsc.ie    Spain Vall d'Hebron University Hospital Recruiting Barcelona, Spain, 08035 Contact: Soledad Gallego, MD, PhD    34-93-489-3090    sgallego@vhebron.net    Sweden Uppsala University Hospital Recruiting Uppsala, Sweden, SE-75185 Contact: Gustaf Ljungman, MD    46-18-611-5586       Switzerland University Children's Hospital Recruiting Zurich, Switzerland, CH-8032 Contact: Felix Niggli, MD    41-44-266-7823       United Kingdom Birmingham Children's Hospital Recruiting Birmingham, England, United Kingdom, B16 8ET Contact: David Hobin, MD    44-121-454-4851       Institute of Child Health at University of Bristol Recruiting Bristol, England, United Kingdom, BS2 8AE Contact: M. C. G. Stevens, MD    44-117-342-0205    m.stevens@bristol.ac.uk    Addenbrooke's Hospital Recruiting Cambridge, England, United Kingdom, CB2 2QQ Contact: Denise Williams, MD    44-1223-256-298       Leeds Cancer Centre at St. James's University Hospital Recruiting Leeds, England, United Kingdom, LS9 7TF Contact: Martin Elliott, MD    44-113-206-4988       Leicester Royal Infirmary Recruiting Leicester, England, United Kingdom, LE1 5WW Contact: Johann Visser, MD    44-116-258-5309    johannes.visser@uhl-tr.nhs.uk    Royal Liverpool Children's Hospital, Alder Hey Recruiting Liverpool, England, United Kingdom, L12 2AP Contact: Heather P. McDowell, MD    44-151-293-3679       Middlesex Hospital Recruiting London, England, United Kingdom, W1T 3AA Contact: Ananth Shankar, MD    44-20-7380-9300 ext. 9950       Great Ormond Street Hospital for Children Recruiting London, England, United Kingdom, WC1N 3JH Contact: Julia Chisholm, MD    44-20-7829-7924       Royal Manchester Children's Hospital Recruiting Manchester, England, United Kingdom, M27 4HA Contact: Bernadette Brennan, MD    44-161-922-2227    bernadette.brennan@cmmc.nhs.uk    Sir James Spence Institute of Child Health at Royal Victoria Infirmary Recruiting Newcastle-Upon-Tyne, England, United Kingdom, NE1 4LP Contact: Juliet Hale, MD    44-191-282-4101    j.p.hale@ncl.ac.uk    Queen's Medical Centre Recruiting Nottingham, England, United Kingdom, NG7 2UH Contact: Martin Hewitt, MD, BSc, FRCP, FRCPCH    44-115-924-9924 ext. 63394    martin.hewitt@nuh.nhs.uk    Oxford Radcliffe Hospital Recruiting Oxford, England, United Kingdom, 0X3 9DU Contact: Sheila Lane, MD    44-1865-234-205       Children's Hospital - Sheffield Recruiting Sheffield, England, United Kingdom, S10 2TH Contact: Mary P. Gerrard, MBChB, FRCP, FRCPCH    44-114-271-7366    mary.gerrard@sch.nhs.uk    Southampton General Hospital Recruiting Southampton, England, United Kingdom, SO16 6YD Contact: Janice A. Kohler, MD, FRCP    44-23-8079-6942       Royal Marsden - Surrey Recruiting Sutton, England, United Kingdom, SM2 5PT Contact: Kathy Pritchard-Jones, MD    44-20-8661-3452 ext 3498       Royal Belfast Hospital for Sick Children Recruiting Belfast, Northern Ireland, United Kingdom, BT12 6BE Contact: Anthony McCarthy, MD    44-289-063-3631    anthonymcarthy@royalhospital.n.i.nhs.uk    Royal Aberdeen Children's Hospital Recruiting Aberdeen, Scotland, United Kingdom, AB25 2ZG Contact: Derek King, MD    44-1224-681-818       Royal Hospital for Sick Children Recruiting Edinburgh, Scotland, United Kingdom, EH9 1LF Contact: W. Hamish Wallace, MD    44-131-536-0426       Royal Hospital for Sick Children Recruiting Glasgow, Scotland, United Kingdom, G3 8SJ Contact: Milind D. Ronghe, MD    44-141-201-9309       Childrens Hospital for Wales Recruiting Cardiff, Wales, United Kingdom, CF14 4XW Contact: Meriel Jenney, MD    44-292-074-2107 Less <<
NCT00023738 Sarcoma Phase 1 Phase 2 Completed - -
NCT00002566 Extragonadal Germ Cell Tumor ... More >> Testicular Germ Cell Tumor Less << Phase 3 Unknown - France ... More >> Institut Gustave Roussy Villejuif, France, F-94805 Less <<
NCT00274950 Childhood Germ Cell Tumor ... More >> Extragonadal Germ Cell Tumor Ovarian Cancer Less << Phase 3 Unknown - Ireland ... More >> Our Lady's Hospital for Sick Children Crumlin Dublin, Ireland, 12 United Kingdom Birmingham Children's Hospital Birmingham, England, United Kingdom, B4 6NH Institute of Child Health at University of Bristol Bristol, England, United Kingdom, BS2 8AE Addenbrooke's Hospital Cambridge, England, United Kingdom, CB2 2QQ Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Leicester Royal Infirmary Leicester, England, United Kingdom, LE1 5WW Royal Liverpool Children's Hospital, Alder Hey Liverpool, England, United Kingdom, L12 2AP Royal London Hospital London, England, United Kingdom, E1 1BB Great Ormond Street Hospital for Children London, England, United Kingdom, WC1N 3JH Royal Manchester Children's Hospital Manchester, England, United Kingdom, M27 4HA Sir James Spence Institute of Child Health at Royal Victoria Infirmary Newcastle-Upon-Tyne, England, United Kingdom, NE1 4LP Queen's Medical Centre Nottingham, England, United Kingdom, NG7 2UH Children's Hospital - Sheffield Sheffield, England, United Kingdom, S10 2TH Southampton General Hospital Southampton, England, United Kingdom, SO16 6YD Royal Marsden - Surrey Sutton, England, United Kingdom, SM2 5PT Royal Belfast Hospital for Sick Children Belfast, Northern Ireland, United Kingdom, BT12 6BE Royal Aberdeen Children's Hospital Aberdeen, Scotland, United Kingdom, AB25 2ZG Royal Hospital for Sick Children Edinburgh, Scotland, United Kingdom, EH9 1LF Royal Hospital for Sick Children Glasgow, Scotland, United Kingdom, G3 8SJ Childrens Hospital for Wales Cardiff, Wales, United Kingdom, CF14 4XW Less <<
NCT00148395 Non-Small-Cell Lung Carcinoma Phase 3 Completed - Germany ... More >> Klinikum Kassel GmbH Kassel, Germany, 34125 Less <<
NCT00652860 Metastatic Cancer ... More >> Sarcoma Less << Phase 2 Completed - -
NCT00004172 Breast Cancer Phase 2 Completed - United States, Illinois ... More >> Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States, 60611 Less <<
NCT00302003 Childhood Favorable Prognosis ... More >>Hodgkin Lymphoma Childhood Lymphocyte Depletion Hodgkin Lymphoma Childhood Mixed Cellularity Hodgkin Lymphoma Childhood Nodular Sclerosis Hodgkin Lymphoma Stage I Childhood Hodgkin Lymphoma Stage II Childhood Hodgkin Lymphoma Less << Phase 3 Unknown - United States, California ... More >> Children's Oncology Group Arcadia, California, United States, 91006-3776 Less <<
NCT00023998 Metastatic Osteosarcoma Phase 2 Completed - United States, California ... More >> Children's Oncology Group Arcadia, California, United States, 91006-3776 Less <<
NCT00022737 Childhood Acute Lymphoblastic ... More >>Leukemia in Remission Recurrent Childhood Acute Lymphoblastic Leukemia Less << Phase 3 Completed - United States, California ... More >> Children's Oncology Group Arcadia, California, United States, 91006-3776 Less <<
NCT00025363 Alveolar Childhood Rhabdomyosa... More >>rcoma Embryonal Childhood Rhabdomyosarcoma Embryonal-botryoid Childhood Rhabdomyosarcoma Previously Treated Childhood Rhabdomyosarcoma Recurrent Childhood Rhabdomyosarcoma Less << Phase 2 Completed - United States, California ... More >> Children's Oncology Group Arcadia, California, United States, 91006-3776 Less <<
NCT00720109 Adult B Acute Lymphoblastic Le... More >>ukemia With t(9;22)(q34;q11.2); BCR-ABL1 Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34;q11.2); BCR-ABL1 Untreated Adult Acute Lymphoblastic Leukemia Untreated Childhood Acute Lymphoblastic Leukemia Less << Phase 2 Phase 3 Completed - -
NCT00302003 - Unknown - -
NCT00618813 - Completed - -
NCT00696735 Follicular Lymphoma Phase 3 Completed - France ... More >> Emmanuel GYAN Tours, France, 37000 Philippe COLOMBAT Tours, France, 37000 Less <<
NCT00720109 - Completed - -
NCT00004132 Drug/Agent Toxicity by Tissue/... More >>Organ Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Oral Complications Radiation Toxicity Less << Phase 2 Completed - United States, California ... More >> Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States, 90095-1781 Less <<
NCT00618813 Ewing Sarcoma of Bone ... More >> Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Less << Not Applicable Completed - United States, California ... More >> Children's Oncology Group Monrovia, California, United States, 91016 Less <<
NCT03007147 B Acute Lymphoblastic Leukemia... More >> BCR-ABL1 Fusion Protein Expression Minimal Residual Disease Philadelphia Chromosome Positive T Acute Lymphoblastic Leukemia Untreated Adult Acute Lymphoblastic Leukemia Untreated Childhood Acute Lymphoblastic Leukemia Less << Phase 3 Recruiting June 30, 2026 -
NCT02112916 Adult T Acute Lymphoblastic Le... More >>ukemia Ann Arbor Stage II Adult Lymphoblastic Lymphoma Ann Arbor Stage II Childhood Lymphoblastic Lymphoma Ann Arbor Stage III Adult Lymphoblastic Lymphoma Ann Arbor Stage III Childhood Lymphoblastic Lymphoma Ann Arbor Stage IV Adult Lymphoblastic Lymphoma Ann Arbor Stage IV Childhood Lymphoblastic Lymphoma Childhood T Acute Lymphoblastic Leukemia Untreated Adult Acute Lymphoblastic Leukemia Untreated Childhood Acute Lymphoblastic Leukemia Less << Phase 3 Suspended(Other - Temporary cl... More >>osure) Less << - -
NCT02845882 Lymphoblastic Lymphoma Phase 2 Phase 3 Recruiting December 2025 China ... More >> West China Second University Hospital Recruiting Chengdu, China Contact: Xia Guo, M.D.       guoxkl@163.com    Shanghai Children's Medical Center Recruiting Shanghai, China, 200127 Contact: Yi-Jin Gao, M.D.    86-21-38626161 ext 82064    gaoyijin@scmc.com.cn    Contact: Jing-yan Gao, M.D. Less <<
NCT00004086 Leukemia Lymp... More >>homa Less << Phase 1 Unknown - United States, New Jersey ... More >> Garden State Cancer Center Belleville, New Jersey, United States, 07103 Less <<
NCT01172912 Brain and Central Nervous Syst... More >>em Tumors Extragonadal Germ Cell Tumor Testicular Germ Cell Tumor Less << Phase 2 Unknown - Italy ... More >> Fondazione Istituto Nazionale dei Tumori Recruiting Milan, Italy, 20133 Contact: Contact Person    39-02-2390-2532    alessandro.gianni@unimi.it Less <<
NCT03450343 Large B-Cell Diffuse Lymphoma Phase 1 Recruiting March 28, 2021 United States, South Carolina ... More >> Medical University of South Carolina Recruiting Charleston, South Carolina, United States, 29425 Contact: Shanta Salzer    843-792-9321    hcc-clinical-trials@musc.edu Less <<
NCT00613457 Leukemia Phase 3 Completed - -
NCT00014300 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - Austria ... More >> Kaiser Franz Josef Hospital Vienna (Wien), Austria, A-1100 France Centre Jean Perrin Clermont-Ferrand, France, 63011 Centre de Lute Contre le Cancer,Georges-Francois Leclerc Dijon, France, 21079 Centre Leon Berard Lyon, France, 69373 CRLCC Nantes - Atlantique Nantes-Saint Herblain, France, 44805 Centre Antoine Lacassagne Nice, France, 06189 CHU Pitie-Salpetriere Paris, France, 75651 Centre Eugene Marquis Rennes, France, 35064 Institut Gustave Roussy Villejuif, France, F-94805 Greece University of Ioannina Ioannina, Greece, GR-45110 Israel Schneider Children's Medical Center of Israel Petah-Tikva, Israel, 49202 Italy Azienda Ospedaliera di Padova Padova (Padua), Italy, 35128 Istituti Fisioterapici Ospitalieri - Roma Rome, Italy, 00161 Netherlands Rotterdam Cancer Institute Rotterdam, Netherlands, 3075 EA Academisch Ziekenhuis Utrecht Utrecht, Netherlands, 3508 GA Portugal Instituto Portugues de Oncologia de Francisco Gentil Lisbon, Portugal, 1093 Switzerland Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 Kantonsspital - St. Gallen St. Gallen, Switzerland, CH-9007 Less <<
NCT00099294 Pancreatic Cancer Phase 3 Completed - -
NCT00005055 Lung Cancer Phase 2 Completed - France ... More >> CRLCC Nantes - Atlantique Nantes-Saint Herblain, France, 44805 Less <<
NCT02788201 Urothelial Carcinoma ... More >> Bladder Cancer Urinary Bladder Neoplasms Less << Phase 2 Recruiting July 1, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT00441467 - Completed - -
NCT02533700 Peripheral T-Cell Lymphoma ... More >> Angioimmunoblastic T Cell Lymphoma ALK-negative Anaplastic Large Cell Lymphoma Enteropathy Associated T Cell Lymphoma Subcutaneous Panniculitis Like T Cell Lymphoma Acute Adult T-Cell Leukemia/Lymphoma Less << Phase 4 Unknown December 2017 China, Shandong ... More >> Shandong Provincial Hospital Recruiting Jinan, Shandong, China, 250021 Contact: Xin Wang, MD, PHD    86-531-13156012606    xinw@sdu.edu.cn    Contact: Yujie Jiang, MD    86-531-13370506886    yujiejiang05@126.com Less <<
NCT00441467 Soft Tissue Sarcoma Phase 2 Completed - United States, Arizona ... More >> Premiere Oncology of Arizona Scottsdale, Arizona, United States, 85260 Arizona Cancer Center Tucson, Arizona, United States, 85724 United States, California Stanford Cancer Center Stanford, California, United States, 94305 United States, Florida H. Lee Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Missouri Washington University School of Medicine, Division of Oncology St. Louis, Missouri, United States, 63110 United States, New Mexico University of New Mexico Cancer Research and Treatment Center Albuquerque, New Mexico, United States, 87131 United States, New York St. Vincent's Comprehensive Cancer Center New York, New York, United States, 10011 Less <<
NCT03643276 Acute Lymphoblastic Leukemia, ... More >>Pediatric Less << Phase 3 Recruiting July 14, 2028 -
NCT00005053 Pancreatic Cancer Phase 2 Completed - Denmark ... More >> Herlev Hospital - University Hospital of Copenhagen Herlev, Denmark, DK-2730 France Centre Leon Berard Lyon, France, 69373 CHU de la Timone Marseille, France, 13385 Centre Eugene Marquis Rennes, France, 35064 Centre Henri Becquerel Rouen, France, 76038 Germany Universitats-Krankenhaus Eppendorf Hamburg, Germany, D-20246 Medizinische Hochschule Hannover Hannover, Germany, D-30625 Haemato-Onkologische Praxis und Tagesklinik Munich, Germany, D-80639 Klinikum Nurnberg Nuremberg, Germany, D-90419 Greece University of Ioannina Ioannina, Greece, GR-45110 Israel Rambam Medical Center Haifa, Israel, 31096 Netherlands Academisch Ziekenhuis der Vrije Universiteit Amsterdam, Netherlands, 1117 MB Switzerland Inselspital, Bern Bern, Switzerland, CH-3010 Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 Kantonsspital - Saint Gallen Saint Gallen, Switzerland, CH-9007 Less <<
NCT01501149 Nasal and Nasal-type NK/T-cell... More >> Lymphoma Less << Phase 4 Recruiting May 2019 China, Henan ... More >> Oncology Department of The First Affiliated Hospital of Zhengzhou University Recruiting Zhengzhou, Henan, China, 450052 Contact: Mingzhi Zhang, Pro,Dr       mingzhi_zhang@126.com    Principal Investigator: Mingzhi Zhang, Pro,Dr Less <<
NCT01296659 Soft Tissue Sarcoma Phase 1 Withdrawn(Principal Investigat... More >>or left institution.) Less << - United States, Texas ... More >> Cancer Therapy & Research Center at UTHSCSA San Antonio, Texas, United States, 78229 Less <<
NCT00002791 Sarcoma Phase 2 Completed - -
NCT00002697 Lymphoma Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT02560441 Extranodal Natural Killer/T-Ce... More >>ll Lymphoma, Nasal Type Less << Phase 2 Recruiting - China ... More >> Cancer Institute/Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College Recruiting Beijing, China Contact: Yuankai Shi          People's Hospital of Guangxi Recruiting Nanning, China Contact: Jiaxin Chen          Fourth Hospital of Hebei Medical University Recruiting Shijiazhuang, China Contact: Yuhuan Gao          Shanxi Dayi Hospital Recruiting Taiyuan, China Contact: Qiaohua Zhang          Shanxi Province Cancer Hospital Recruiting Taiyuan, China Contact: Liping Su Less <<
NCT01361191 Diffuse Large B-cell Lymphoma ... More >> Follicular Grade 3B Lymphoma Less << Phase 2 Completed - Spain ... More >> ICO- Hospital Duran i Reynals Hospitalet de Llobregat, Barcelona, Spain, 08907 Hospital de Jerez Jerez de la Frontera, Cádiz, Spain, 11407 Hospital Clínico Univ. de Santiago Santiago de Compostela, Galicia, Spain, 15706 Hospital Univ. Son Dureta Palma de Mallorca, Mallorca, Spain, 07014 Hospital Son Llàtzer Palma de Mallorca, Mallorca, Spain, 07198 Hospital Universitario de Canarias La Laguna, Santa Cruz de Tenerife, Spain, 38320 Complejo Hospitalario de Jaén Jaén, Spain, 23006 Hospital Universitario La Princesa Madrid, Spain, 28006 Hospital Universitario Gregorio Marañon Madrid, Spain, 28007 Hospital Universitario 12 de Octubre Madrid, Spain, 28041 Hospital Universitario La Paz Madrid, Spain, 28046 Hospital Univ. Morales Meseguer Murcia, Spain, 30008 Clínica Universitaria de Navarra Pamplona, Spain, 31008 Hospital Universitario de Salamanca Salamanca, Spain, 37007 Hospital Universitario Marques de Valdecilla Santander, Spain, 39008 Hospital General de Segovia Segovia, Spain, 40002 Hospital Universitario Río Hortega Valladolid, Spain, 47010 Hospital Universitario Virgen de la Concha Zamora, Spain, 49022 Hospital Clínico Lozano Blesa Zaragoza, Spain, 50009 Less <<
NCT00002931 - Completed - -
NCT00002931 Brain and Central Nervous Syst... More >>em Tumors Extragonadal Germ Cell Tumor Ovarian Cancer Teratoma Testicular Germ Cell Tumor Less << Phase 2 Completed - United States, California ... More >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010-3000 Less <<
NCT02789384 Soft-tissue Sarcomas Not Applicable Recruiting January 2021 France ... More >> Institut Bergonié Recruiting Bordeaux, France, 33076 Contact: Antoine ITALIANO, MD,PhD          Principal Investigator: ITALIANO Antoine, MD,PhD          Centre Georges François Leclerc Not yet recruiting Dijon Cedex, France, 21079 Principal Investigator: ISAMBERT Nicolas, MD          Centre Oscar Lambret Not yet recruiting Lille Cedex, France, 59020 Principal Investigator: PENEL Nicolas, MD          Centre Léon Bérard Not yet recruiting Lyon Cedex 08, France, 69373 Principal Investigator: BLAY Jean-Yves, MD,PhD          AP-HM _ Hôpital de la Timone Not yet recruiting Marseille Cedex 05, France, 13385 Principal Investigator: DUFFAUD Florence, MD,PhD          Institut Paoli Calmettes Not yet recruiting Marseille Cedex 9, France, 13273 Principal Investigator: BERTUCCI François, MD,PhD          Institut de Cancérologie de l'Ouest Not yet recruiting Nantes, France, 44805 Principal Investigator: BOMPAS Emmanuel, MD          Institut Curie Not yet recruiting Paris Cedex, France, 75005 Principal Investigator: PIPERNO-NEUMANN Sophie, MD          Institut Claudius Regaud - IUCT-0 Not yet recruiting Toulouse Cedex 9, France, 31052 Principal Investigator: CHEVREAU Christine, MD          Institut Gustave Roussy Not yet recruiting Villejuif Cedex, France, 94805 Principal Investigator: LECESNE Axel, MD Less <<
NCT00689845 Lymphoma Not Applicable Unknown - United Kingdom ... More >> Leeds Cancer Centre at St. James's University Hospital Recruiting Leeds, England, United Kingdom, LS9 7TF Contact: Contact Person    44-113-206-6400       St. George's Hospital Recruiting London, England, United Kingdom, SW17 0QT Contact: Contact Person    44-208-725-2425    rpetteng@sghms.ac.uk    Christie Hospital Recruiting Manchester, England, United Kingdom, M20 4BX Contact: Contact Person    44-845-226-3000       Mount Vernon Cancer Centre at Mount Vernon Hospital Recruiting Northwood, England, United Kingdom, HA6 2RN Contact: Contact Person    44-1923-826-111       Cancer Research Centre at Weston Park Hospital Recruiting Sheffield, England, United Kingdom, S1O 2SJ Contact: Contact Person    44-114-226-5007    b.w.hancock@sheffield.ac.uk    Southampton General Hospital Recruiting Southampton, England, United Kingdom, SO16 6YD Contact: Contact Person    44-238-079-6186    johnsonp@soton.ac.uk    Royal Marsden - Surrey Recruiting Sutton, England, United Kingdom, SM2 5PT Contact: Contact Person    44-208-661-3279    david.cunningham@rmh.nhs.uk    Saint Bartholomew's Hospital Recruiting London, United Kingdom Contact: Contact Person    44-207-796-3979    silvia.montoto@cancer.org.uk Less <<
NCT02371161 Non Hodgkin Lymphoma Phase 2 Recruiting February 2023 Italy ... More >> A.O. SS.Antonio e Biagio e C. Arrigo Recruiting Alessandria, AL, Italy, 15121 Contact: Flavia Salvi, MD    0131-206066    fsalvi@ospedale.al.it    Principal Investigator: Flavia Salvi, MD          Ospedali Riuniti Recruiting Ancona, AN, Italy, 60126 Contact: Attilio Olivieri, MD    071-5964226    a.olivieri@univpm.it    Principal Investigator: Attilio Olivieri, MD          Ospedale Perrino Active, not recruiting Brindisi, BR, Italy, 72100 Spedali Civili Recruiting Brescia, BS, Italy, 25123 Contact: Alessandra Tucci, MD    030-3995438    alessandra.tucci@spedalicivili.brescia.it    Principal Investigator: Alessandra Tucci, MD          Policlinico Vittorio Emanuele Active, not recruiting Catania, CT, Italy, 95123 Casa Sollievo della Sofferenza Active, not recruiting San Giovanni Rotondo, FG, Italy, 71013 IRST Meldola Recruiting Meldola, Forlì-Cesena, Italy, 47014 Contact: Gerardo Musuraca    0543-739291    g.musuraca@irst.emr.it    Principal Investigator: Gerardo Musuraca, MD          IRCCS San Martino - IST Active, not recruiting Genova, GE, Italy, 16132 ASUR Marche, Area Vasta 3 Active, not recruiting Civitanova Marche, MC, Italy, 62012 AO Riuniti Papardo Piemonte Recruiting Messina, ME, Italy, 98158 Contact: Donato Mannina, MD    090-3992239    donamanni@gmail.com    Principal Investigator: Donato Mannina, MD          IRCCS Humanitas Recruiting Rozzano, Milano, Italy, 20089 Contact: Luca Castagna, MD    02-82244580    luca.castagna@humanitas.it    Principal Investigator: Luca Castagna, MD          AO Niguarda Ca' Granda Recruiting Milano, MI, Italy, 20162 Contact: Chiara Rusconi, MD    02-64442668    chiara.rusconi@ospedaleniguarda.it    Principal Investigator: Chiara Rusconi, MD          Ospedale Civile "Guglielmo da Saliceto" Recruiting Piacenza, PC, Italy, 29100 Contact: Daniele Vallisa, MD    0523-303719    d.vallisa@ausl.pc.it    Principal Investigator: Danilele Vallisa, MD          Centro di Riferimento Oncologico Recruiting Aviano, PN, Italy, 33081 Contact: Mariagrazia Michieli, MD    0434-659601    mmichieli@cro.it    Principal Investigator: Mariagrazia Michieli, MD          Azienda Ospaliero Universitaria di Parma Recruiting Parma, PR, Italy, 43126 Contact: Francesca Re, MD    0521-033306    fre@ao.pr.it    Principal Investigator: Francesca Re, Prof.          Ospedale San Carlo Active, not recruiting Potenza, PZ, Italy, 85100 AUSL di Ravenna Recruiting Ravenna, RA, Italy, 48100 Contact: Monica Tani, MD    0544-286223    monica.tani@ausl.ra.it    Principal Investigator: Monica Tani, MD          A.O. Bianchi - Melacrino - Morelli Active, not recruiting Reggio Calabria, RC, Italy, 89125 Asmn-Irccs Recruiting Reggio Emilia, RE, Italy, 43123 Contact: Francesco Merli, MD    0522-296618    merli.francesco@asmn.re.it    Principal Investigator: Francesco Merli, MD          Policlinico Sant'Andrea Recruiting Roma, RM, Italy, 00189 Contact: Maria Christina Cox, MD    338-2268017    chrisscox@gmail.com    Principal Investigator: Maria Christina Cox, MD          Ospedale Nocera- Pagani Active, not recruiting Nocera Inferiore, SA, Italy, 84014 AOU San Giovanni e Ruggi Active, not recruiting Salerno, SA, Italy, 84131 AOU Città della Salute e della Scienza Recruiting Torino, TO, Italy, 10126 Contact: Federica Cavallo, MD    011-6334301    f.cavallo@unito.it    Principal Investigator: Federica Cavallo, MD          Ospedale Mauriziano Active, not recruiting Torino, TO, Italy, 10128 AO Santa Maria Active, not recruiting Terni, TR, Italy, 05100 Ospedale S.Andrea Active, not recruiting Vercelli, VC, Italy, 13100 Ospedale degli Infermi Recruiting Rimini, Italy, 47923 Contact: Anna Lia Molinari    0541-705423    annalia.molinari@auslromagna.it    Principal Investigator: Anna Lia Molinari, MD Less <<
NCT00002524 Lymphoma Phase 2 Completed - United States, Florida ... More >> MD Anderson Cancer Center Orlando Orlando, Florida, United States, 32806 United States, Texas University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00028860 Bladder Cancer ... More >> Transitional Cell Cancer of the Renal Pelvis and Ureter Less << Phase 2 Completed - United States, Louisiana ... More >> Tulane Cancer Center at Tulane University Hospital and Clinic New Orleans, Louisiana, United States, 70112 Less <<
NCT03643133 Osteosarcoma Phase 2 Recruiting October 2028 France ... More >> Institut Curie Not yet recruiting Paris, France, 75000 Contact: Sophie MD PIPERNO-NEUMANN, PhD    33 (0)144324672    sophie.piperno-neumann@curie.fr    Gustave Roussy Recruiting Villejuif, France, 94800 Contact: Nathalie MD GASPAR, PhD    33 (0)142114166    nathalie.gaspar@gustaveroussy.fr Less <<
NCT00004061 Leukemia Lymp... More >>homa Oral Complications Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00005977 Leukemia Lymp... More >>homa Less << Phase 3 Completed - -
NCT03137641 - Recruiting October 16, 2018 France ... More >> Hôpital Pellegrin Recruiting Bordeaux, France, 33000 Contact: VERDUN-ESQUER Catherine, Dr    5 56 79 61 65 ext +33    catherine.verdun-esquer@chu-bordeaux.fr    Contact: CANAL-RAFFIN Mireille, Dr    5 56 79 59 91 ext +33    mireille.raffin@chu-bordeaux.fr    Sub-Investigator: PARTARRIEU Isabelle, Dr          Sub-Investigator: VIDEAU Nathalie, Dr          Sub-Investigator: LAPLACE Véronique, Dr          Principal Investigator: VERDUN-ESQUER Catherine, Dr          CHU de Toulouse Recruiting Toulouse, France, 31000 Contact: MARPINARD Monique, Dr       Marpinard.Monique@iuct-oncopole.fr    IUCT-Oncopole Recruiting Toulouse, France, 31000 Contact: MARPINARD Monique, Dr    5 31 15 50 30 ext +33    Marpinard.Monique@iuct-oncopole.fr    Contact: PORTES Eric       Portes.Eric@iuct-oncopole.fr    Principal Investigator: MARPINARD Monique, Dr Less <<
NCT01290120 Burkitt Lymphoma ... More >> B-ALL Less << Phase 2 Completed - Italy ... More >> Divisione di Ematologia e TMO, Ospedale San Maurizio Bolzano, (bz), Italy Ematologia e centro TMO - Ospedale Armando Businco Cagliari, (ca), Italy S.C. Ematologia - Azienda Ospedaliera S. Croce e Carle Cuneo, (cn), Italy Onco-Ematologia - Ospedale Civile Noale, (ve), Italy Dipartimento di Ematologia e Medicina Trasfusionale - Azienda Osp. Nazionale Santi Antonio e Biagio e Cesare Arrigo Alessandria, AL, Italy USC Ematologia Ospedali Riuniti di Bergamo Bergamo, BG, Italy Divisione Ematologia Spedali Civili Brescia, BS, Italy, 25123 Ematologia - AOU Careggi Firenze, FI, Italy Ematologia e TMO - Ospedale San Raffaele Milano, MI, Italy Ematologia - TMO - Ospedale San Gerardo Monza, MI, Italy Ematologia Ospedale San Bortolo Vicenza, VI, Italy, 36100 USC Ematologia Ospedali Riuniti di Bergamo Bergamo, Italy, 24128 Less <<
NCT03558412 T-lymphoblastic Lymphoma Phase 4 Recruiting June 1, 2020 China, Henan ... More >> Oncology Department of The First Affiliated Hospital of Zhengzhou University Recruiting Zhengzhou, Henan, China, 450052 Contact: Mingzhi Zhang, Pro,Dr    13838565629    mingzhi_zhang@126.com    Contact: Mingzhi Zhang, Pro,Drc    13838565629    mingzhi_zhang@126.com Less <<
NCT00006515 - Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00005631 Lymphoma Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT01007526 Stage I/II Extranodal NK/T-cel... More >>l Lymphoma Less << Phase 2 Unknown December 2012 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of, 135-710 Principal Investigator: Won Seog Kim, MD, PhD Less <<
NCT00134030 Localized Osteosarcoma ... More >> Metastatic Osteosarcoma Less << Phase 3 Active, not recruiting - -
NCT02471027 - Not yet recruiting June 2019 China, Beijing ... More >> Beijing Obstetrics and Gynecology Hospital, Capital Medical University Beijing, Beijing, China, 100000 Less <<
NCT00003631 Lymphoma Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00020566 Sarcoma Phase 3 Unknown - -
NCT03011528 Ewing Sarcoma Family of Tumors Phase 2 Recruiting December 2022 France ... More >> Chr Felix Guyon Not yet recruiting La Réunion, Saint Denis, France, 97400 Principal Investigator: Yves REGUERRE, MD          Bordeaux Chu Recruiting Bordeaux, France, 33076 Contact: Cécile VERITE-GOULARD, MD    +33(0)556795430    cecile.verite@chu-bordeaux.fr    CHU Grenoble Alpes Not yet recruiting Grenoble, France, 38043 Principal Investigator: Dominique PLANTAZ, P          LILLE Centre Oscar Lambret Recruiting Lille, France, 59000 Contact: Cyril LERVAT, MD    +33(0)320295935    c-lervat@o-lambret.fr    LYON Centre Léon Bérard Recruiting Lyon, France, 69000 Contact: Nadège CORRADINI, MD    +33(0)469166572    nadege.corradini@lyon-unicancer.fr    Marseille Chu Not yet recruiting Marseille, France, 13000 Contact: Jean-Claude GENTET, MD    +33(0)491386821    jcgentet@ap-hm.fr    CHRU Montpellier - Hôpital A. de Villeneuve Recruiting Montpellier, France, 34295 Principal Investigator: Laure SAUMET, MD          Nantes Chu Recruiting Nantes, France, 44000 Contact: Estelle THEBAUD, MD    +33(0)240083810    estelle.thebaud@chu-nantes.fr    PARIS Institut Curie Recruiting Paris, France, 75005 Contact: Valérie LAURENCE, MD    +33(0)1 44 32 42 07    valerie.laurence@curie.fr    PARIS Trousseau Recruiting Paris, France, 75012 Contact: Marie-Domnique TABONE, MD    +33(0)144736062    marie-dominique.tabone@aphp.fr    CHU Hôpital Sud Not yet recruiting Rennes, France, 35056 Principal Investigator: Sophie TAQUE, MD          Strasbourg Chu Recruiting Strasbourg, France, 67098 Contact: Natacha ENTZ-WERLE, MD    +33(0)388128072    natacha.entz-werle@chu-strasbourg.fr    Toulouse Chu Recruiting Toulouse, France, 31059 Contact: Marie-Pierre CASTEX, MD    +33(0)534558610    castex.mp@chu-toulouse.fr    TOULOUSE Institut Claudius Regaud Recruiting Toulouse, France, 31059 Contact: Christine CHEVREAU, MD    +33(0)531155151    chevreau.christine@iuct-oncopole.fr    NANCY Institut de Cancérologie de Lorraine Not yet recruiting Vandoeuvre les Nancy, France, 54519 Contact: Maria RIOS, MD    +33(0)383598358    m.rios@nancy.unicancer.fr    Nancy Chu Recruiting Vandoeuvre-les-Nancy, France, 54511 Contact: Ludovic MANSUY, MD    +33(0)383154734    l.mansuy@chu-nancy.fr    VILLEJUIF Institut Gustave Roussy Recruiting Villejuif, France, 94805 Contact: Nathalie GASPAR, MD    +33(0)142114166    nathalie.gaspar@gustaveroussy.fr Less <<
NCT00003631 - Completed - -
NCT00004853 Ewing's Sarcoma ... More >> Rhabdomyosarcoma MPNST Synovial Sarcoma High-risk Sarcoma Less << Phase 1 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00432094 Childhood Germ Cell Tumor ... More >> Ovarian Cancer Teratoma Less << Phase 2 Recruiting January 2019 United States, Minnesota ... More >> Masonic Cancer Center at University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Brian McClune, DO    612-273-2800    bmcclune@umn.edu Less <<
NCT02164097 Recurrent Solid Tumor ... More >> Refractory Solid Tumor Sarcoma Wilms' Tumor Neuroblastoma Less << Phase 1 Terminated(low accrual) - United States, New York ... More >> New York Medical College Valhalla, New York, United States, 10595 Less <<
NCT00003860 Lung Cancer Phase 2 Unknown - France ... More >> CHR de Besancon - Hopital Saint-Jacques Besancon, France, 25030 Institut Bergonie Bordeaux, France, 33076 CMC Bligny Briis Sous Forges, France, 91640 Centre de Lute Contre le Cancer,Georges-Francois Leclerc Dijon, France, 21079 CHR de Grenoble - La Tronche Grenoble, France, 38043 Centre Leon Berard Lyon, France, 69373 Hopital Louis Pradel Lyon, France, 69394 Institut J. Paoli and I. Calmettes Marseille, France, 13273 Hopital Arnaud de Villeneuve Montpellier, France, 34295 Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle Montpellier, France, 34298 Centre Antoine Lacassagne Nice, France, 06189 Institut Curie - Section Medicale Paris, France, 75248 Hopital Saint Antoine Paris, France, 75571 Hopital Tenon Paris, France, 75970 Hopital Jules Courmont - Centre Hospitalier Lyon Sud Pierre Benite, France, 69495 Hopital Rene Dubos Pontoise, France, 95300 Institut Jean Godinot Reims, France, 51056 Centre Rene Huguenin Saint Cloud, France, 92210 Hopitaux Universitaire de Strasbourg Strasbourg, France, 67091 Institut Claudius Regaud Toulouse, France, 31052 CHRU de Nancy - Hopitaux de Brabois Vandoeuvre-Les-Nancy, France, 54511 Institut Gustave Roussy Villejuif, France, F-94805 Less <<
NCT00815945 Mesenchymal Tumor ... More >> Carcinosarcoma Leiomyosarcoma Less << Phase 2 Completed - Germany ... More >> Charité, Campus Virchow Klinikum, Frauenklinik Berlin, Germany, 13353 Malteser Krankenhaus, Gynäkologie und Geburtshilfe Bonn, Germany, 53123 Klinikum Bremen-Mitte gGmbH, Frauenklinik Bremen, Germany, 28177 Universitätsklinikum Carl Gustav Carus, Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe Dresden, Germany, 01307 Evangelisches Krankenhaus Düsseldorf, Frauenklinik Duesseldorf, Germany, 40217 Universitätsklinikum Essen, Frauenklinik Essen, Germany, 45122 Klinikum der J. W. Goethe-Universität, Klinik für Gynäkologie und Geburtshilfe Frankfurt, Germany, 60590 University Hospital Hamburg-Eppendorf Hamburg, Germany, 20251 Gynäkologisch-onkologische Praxis Hannover, Germany, 30177 St. Vincentius Kliniken AG, Frauenklinik Karlsruhe, Germany, 76135 Universitätsklinikum Giessen und Marburg GmbH, Klinik für Gynäkologie, Gynäkologische Endokrinologie und Onkologie Marburg, Germany, 35043 Klinikum Großhadern, Frauenklinik München, Germany, 81377 Universitätsklinikum Tübingen, Frauenklinik Tübingen, Germany, 72076 Universitätsklinikum Ulm, Universitätsfrauenklinik Ulm, Germany, 89075 Dr. Horst Schmidt Kliniken GmbH, Klinik für Gynäkologie und gynäkologische Onkologie Wiesbaden, Germany, 65199 Less <<
NCT03715296 - Not yet recruiting September 15, 2020 China, Shanghai ... More >> Ruijin hospital Shanghai, Shanghai, China, 200025 Less <<
NCT01876043 Adult Patients With Unresectab... More >>le Locally Advanced or Metastatic, Relapsed/Refractory Dedifferentiated Liposarcoma Less << Phase 2 Terminated December 2015 France ... More >> Centre Oscar Lambret Lille, France, 59020 Centre Léon Bérard Lyon, France, 69373 Hôpital de la Timone Marseille, France, 13385 Institut Curie Paris, France, 75005 Institut Claudius Regaud Toulouse, France, 31052 Institut Gustave Roussy Villejuif, France, 94800 Less <<
NCT00001335 Ewing's Sarcoma ... More >> Neuroblastoma Rhabdomyosarcoma Less << Phase 2 Completed - United States, Maryland ... More >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 Less <<
NCT01469975 Sarcoma, Synovial Phase 1 Terminated(Too slow accrual.) - France ... More >> Centre Léon Bérard LYON Cedex 08, France, 69373 Less <<
NCT02405676 Mature B-cell Non-Hodgkin Lymp... More >>homa Less << Phase 2 Phase 3 Recruiting December 2024 China, Sichuan ... More >> West China Second University Hospital of Sichuan University Recruiting Chengdu, Sichuan, China Contact: Yi-Ping Zhu, MD       zhuyiping@918.com    Contact: Xia Guo, MD       guoxkl@163.com Less <<
NCT02433639 Biliary Tract Cancer Phase 2 Completed - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Less <<
NCT01426633 Leiomyosarcoma ... More >> Liposarcoma Less << Phase 1 Completed - Germany ... More >> Mannheim University Medical Center Mannheim, Germany, 68167 Less <<
NCT00517894 - - - -
NCT01995981 - Completed - Netherlands ... More >> Radboud University Nijmegen Medical Centre Nijmegen, Netherlands, 6525 GA United Kingdom Royal Marsden Hospital London, United Kingdom Less <<
NCT00970385 Peripheral T Cell Lymphoma Phase 3 Completed - France ... More >> Dr REMY GRESSIN Grenoble, France, 38043 Less <<
NCT00772694 Testicular Cancer Phase 2 Unknown December 2011 Poland ... More >> Chemotherapy Unit, Dept of Urology, Instituite of Oncology Recruiting Warsaw, Poland, 02781 Principal Investigator: Iwona A Skoneczna, MD          Sub-Investigator: Agnieszka Chaladaj-Kujawska, MD Less <<
NCT01913652 Dedifferentiated Liposarcoma Phase 2 Recruiting February 2019 Belgium ... More >> Universitair Ziekenhuis Antwerpen (117) Recruiting Antwerpen, Belgium Contact: Jan Van Den Brande       jan.van.den.brande@uza.be    Hopitaux Universitaires Bordet-Erasme - Institut Jules Bordet (101) Recruiting Brussels, Belgium Contact: Thierry Gil       thierry.gil@bordet.be    France CHU de Dijon - Centre Georges-Francois-Leclerc (229) Recruiting Dijon, France, 21079 Centre Leon Berard (227) Recruiting Lyon, France Contact: Jean-yves Blay       jean-yves.blay@lyon.unicancer.fr    Assistance Publique - Hopitaux de Marseille - Hôpital de La Timone (287) Recruiting Marseille, France Contact: Florence Duffaud       florence.duffaud@mail.ap-hm.fr    Italy Fondazione IRCCS Istituto Nazionale dei Tumori (704) Recruiting Milano, Italy Contact: Paolo Casali       Paolo.Casali@istitutotumori.mi.it    Istituto Oncologico Veneto IRCCS - Ospedale Busonera (3908) Recruiting Padova, Italy Contact: Umberto Basso       u.basso@tin.it    United Kingdom Clatterbridge Centre for Oncology NHS Trust - Clatterbridge Cancer Centre NHS Foundation Trust (659) Recruiting Bebington, United Kingdom Contact: Nasim Ali       nasim.ali@clatterbridgecc.nhs.uk    Western General Hospital Recruiting Edinburgh, United Kingdom, EH4 2XU Contact: Paul Ramage    0131 537 2916    paul.ramage@rmh.nhs.uk    Contact: Jennifer Waddell    0131 537 2444    jennifer.waddell@rmh.nhs.uk    Principal Investigator: Larry Hayward          Royal Marsden Hospital - Chelsea, London (613) Recruiting London, United Kingdom Contact: Charlotte Benson       charlotte.benson@rmh.nhs.uk    The Christie NHS Foundation Trust (610) Recruiting Manchester, United Kingdom Contact: Michael Leahy       Michael.Leahy@christie.nhs.uk Less <<
NCT02444091 Chronic Fatigue Syndrome (CFS)... More >> Myalgic Encephalomyelitis (ME) Less << Phase 2 Unknown January 2017 Norway ... More >> Dept. of Oncology, Haukeland University Hospital Bergen, Norway, N-5021 Less <<
NCT00187070 Lymphoma, Large Cell ... More >> Lymphoma, Non-Hodgkin Less << Not Applicable Completed - United States, Tennessee ... More >> St. Jude Children's Reaearch Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00392834 Lymphoma Phase 2 Completed - United States, California ... More >> Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States, 92093-0658 USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States, 90089-9181 UCLA Clinical AIDS Research and Education (CARE) Center Los Angeles, California, United States, 90095-1793 UCSF Medical Center at Parnassus San Francisco, California, United States, 94143-0296 United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 United States, Massachusetts Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, Missouri Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis Saint Louis, Missouri, United States, 63110 United States, New York Albert Einstein Cancer Center at Albert Einstein College of Medicine Bronx, New York, United States, 10461 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 United States, Ohio Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210-1240 United States, Pennsylvania Pennsylvania Oncology Hematology Associates, Incorporated - Philadelphia Philadelphia, Pennsylvania, United States, 19106 United States, Washington Floyd and Delores Jones Cancer Institute at Virginia Mason Medical Center Seattle, Washington, United States, 98101 United States, West Virginia West Virginia University Health Sciences Center - Charleston Charleston, West Virginia, United States, 25304 Less <<
NCT02478502 Testicular Cancer Phase 2 Recruiting June 2019 Denmark ... More >> Rigshospitalet Recruiting Copenhagen, Denmark Contact: Gedske Daugaard, MD, PhD    35453545 ext +45    gedske.daugaard@rh.regionh.dk    Principal Investigator: Gedske Daugaard, MD, PhD          Germany University Clinic Hamburg Eppendorf Withdrawn Hamburg, Germany, 20246 Italy Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T) Active, not recruiting Meldola, Italy, 47014 Norway Oslo University Hospital Recruiting Oslo, Norway, N-0424 Contact: Helene Negaard, MD, PhD       UXHEGA@ous-hf.no    Contact: Marit Husby, MD    23026600 ext +47    UXHUMC@ous-hf.no    Principal Investigator: Helene Negaard, MD, PhD          Sweden University Hospital of Uppsala, Department of Oncology Active, not recruiting Uppsala, Sweden, 75185 Less <<
NCT03022448 - Recruiting January 2021 Austria ... More >> Klinikum Klagenfurt am Wörthersee Recruiting Klagenfurt, Austria Contact: Wolfgang Eisterer, Prof. Dr.          Medizinische Universität Wien Recruiting Wien, Austria Contact: Thomas Brodowicz, Prof. Dr.          Germany HELIOS Klinikum Bad Saarow Recruiting Bad Saarow, Germany Contact: Daniel Pink, Dr.          HELIOS Klinikum Berlin Buch Recruiting Berlin, Germany Contact: Peter Reichardt, PD          Klinikum Spandau Recruiting Berlin, Germany Contact: Annegret Kunitz, Dr.          Universitätsklinikum Carl Gustav Carus der TU Dresden Recruiting Dresden, Germany Contact: Stephan Richter, Dr.          Universitätsklinikum Heidelberg Recruiting Heidelberg, Germany Contact: Gerlinde Egerer, Prof. Dr.          University of Heidelberg Mannheim University Medical Center Interdisciplinary Tumor Center, Sarcoma Unit Recruiting Mannheim, Germany Contact: Bernd Kasper, Prof.    +49 621 383 2580    bernd.kasper@umm.de    Klinikum Nürnberg Nord Recruiting Nürnberg, Germany Contact: Marinela Augustin, Dr.          Universitätsklinikum Ulm Recruiting Ulm, Germany Contact: Verena Gaidzik, Dr.          Switzerland Universitätsspital Bern Recruiting Bern, Switzerland Contact: Attila Kollar, Dr. med.          Kantonsspital St. Gallen Recruiting Saint Gallen, Switzerland Contact: Christian Rothermundt, Dr. Less <<
NCT00002565 Lymphoma Phase 3 Completed - United States, Texas ... More >> University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030 Brazil Faculdade de Medicina do ABC Sao Paulo, Brazil, 01224--010 Chile Clinica Alemana Santiago, Chile, 5951 Less <<
NCT01026220 - Completed - -
NCT00807261 Sarcoma Phase 2 Unknown September 2010 -
NCT00345865 Lymphoma Phase 2 Active, not recruiting January 2019 United States, Minnesota ... More >> Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT00392834 - Completed - -
NCT01871766 Rhabdomyosarcoma Phase 2 Recruiting June 2024 United States, Florida ... More >> University of Florida Proton Therapy Institute Active, not recruiting Jacksonville, Florida, United States, 32206 Nemours Children's Clinic Active, not recruiting Jacksonville, Florida, United States, 32207 United States, Tennessee St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Matthew J. Krasin, MD    866-278-5833    referralInfo@stjude.org    Principal Investigator: Matthew J. Krasin, MD          United States, Texas Cook Children's Medical Center Recruiting Fort Worth, Texas, United States, 76104 Contact: Karen Albritton, MD    682-885-2103    karen.albritton@cookchildrens.org    Principal Investigator: Karen Albritton, MD Less <<
NCT00392990 Lymphoma Phase 2 Active, not recruiting October 2019 United States, Illinois ... More >> Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611-3013 John H. Stroger Cook County Hospital Chicago, Illinois, United States, 60612 Rush University Medical Center Chicago, Illinois, United States, 60612 Loyola University Medical Center Maywood, Illinois, United States, 60153 Advocate Lutheran General Cancer Care Center Park Ridge, Illinois, United States, 60068-1174 United States, Missouri Washington University St. Louis, Missouri, United States, 63110 United States, New Jersey The Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08901 United States, Ohio University Hospitals Case Medical Center Cleveland, Ohio, United States, 44106 Less <<
NCT02856997 Peripheral T Cell Lymphoma Phase 2 Not yet recruiting - -
NCT00137995 Lymphoma, Large-Cell, Diffuse Phase 3 Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10021 Australia Australian leukemia and lymphoma group Sydney, Australia Belgium Groupe d'atude des lymphome de l'adulte Yvoir, Belgium Czech Republic Czech Lymphoma study group Praha, Czech Republic Finland Hospital district of south west Finland Turku, Finland Germany German high grade non hodgkin's lymphoma group Hamburg, Germany Israel Israel Society of Hematology Tel-Hashomer, Israel Sweden Nordic center Uppsala, Sweden Switzerland Schweirische Arbeitsgruppe fur klinische Krebsforschung Lausanne, Switzerland United Kingdom National cancer research institute London, United Kingdom Less <<
NCT01026220 Childhood Nodular Lymphocyte P... More >>redominant Hodgkin Lymphoma Stage III Childhood Hodgkin Lymphoma Stage IV Childhood Hodgkin Lymphoma Less << Phase 3 Completed - -
NCT01446809 Stage IIA Adult Soft Tissue Sa... More >>rcoma Stage III Adult Soft Tissue Sarcoma Stage IV Adult Soft Tissue Sarcoma Less << Not Applicable Unknown - United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT01692496 Advanced and / or Metastatic L... More >>iposarcoma Less << Phase 2 Completed - Germany ... More >> HELIOS Klinikum Berlin-Buch (Sarkomzentrum Berlin-Brandenburg) Berlin, Germany, D-10707 Universitätsklinikum EssenInnere Klinik (Tumorforschung) Essen, Germany, D-45147 Medizinische Hochschule Hannover (Zentrum Innere Medizin) Hannover, Germany, D-30625 Universitätsmedizin Mannheim (Sarkomzentrum) Manheim, Germany, D-68169 Klinikum Großhadern der LMU Universität München (Med. Klinik und Poliklinik II) Munich, Germany, D-80336 Spain Hospital Central de Asturias Oviedo, Asturias, Spain, 33011 Hospital Universitario de Canarias La Laguna, Islas Canarias, Spain, 38320 Hospital de Navarra Pamplona, Navarra, Spain, 31008 Complejo Hospitalario Universitario de Vigo Vigo, Pontevedra, Spain, 36204 Hospital Vall d'Hebrón Barcelona, Spain, 08035 Hospital 12 de Octubre Madrid, Spain, 28041 Hospital Universitari Son Espases Palma de Mallorca, Spain, 07010 Hospital Universitario Virgen del Rocío Sevilla, Spain, 41013 Instituto Valenciano de Oncología Valencia, Spain, 46009 Hospital Miguel Servet Zaragoza, Spain, 50009 Less <<
NCT00002764 Endometrial Cancer ... More >> Kidney Cancer Metastatic Cancer Ovarian Cancer Pheochromocytoma Sarcoma Less << Phase 3 Completed - Sweden ... More >> Lund University Hospital Lund, Sweden, SE-22185 Less <<
NCT00002974 Sarcoma Phase 2 Completed - United States, Wisconsin ... More >> University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States, 53792-6164 Less <<
NCT00551122 Brain and Central Nervous Syst... More >>em Tumors Extragonadal Germ Cell Tumor Ovarian Cancer Testicular Germ Cell Tumor Less << Phase 1 Phase 2 Unknown - United Kingdom ... More >> Queen Elizabeth Hospital at University Hospital of Birmingham NHS Trust Recruiting Birmingham, England, United Kingdom, B15 2TH Contact: Michael H. Cullen, MD    0121-627-2444       Southampton General Hospital Recruiting Southampton, England, United Kingdom, SO16 6YD Contact: G. Mead, MD    44-23-8079-8639       Royal Marsden - Surrey Recruiting Sutton, England, United Kingdom, SM2 5PT Contact: Robert A. Huddart, MD    44-20-8661-3457    robert.huddart@icr.ac.uk Less <<
NCT01692678 Advanced or Metastatic Liposar... More >>coma or Leiomyosarcoma Less << Phase 3 Completed - China ... More >> Beijing, China Shanghai, China Less <<
NCT00004916 Lymphoma Phase 1 Phase 2 Completed - United States, Illinois ... More >> Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States, 60611-3013 Less <<
NCT00072215 Extragonadal Germ Cell Tumor ... More >> Testicular Germ Cell Tumor Less << Phase 3 Terminated(poor accrual) - -
NCT00173862 Transitional Cell Carcinoma Phase 2 Completed - Taiwan ... More >> Department of Oncology , National Taiwan University Hospital Taipei, Taiwan, 100 Less <<
NCT00187109 Germ Cell Tumors ... More >> Hepatic Cancer Neuroblastoma Osteosarcoma Rhabdomyosarcoma Less << Phase 1 Phase 2 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00470366 - Completed - -
NCT01258634 Osteosarcoma ... More >>Lung Metastases Less << Phase 1 Terminated(PI no longer affili... More >>ated with institution; only 2 subjects enrolled) Less << - United States, Illinois ... More >> University of Chicago Department of Pediatrics Hematology/Oncology Chicago, Illinois, United States, 60637 Less <<
NCT00061984 Sarcoma Phase 3 Completed - -
NCT00180908 Osteosarcoma ... More >>Localised High Grade Osteosarcoma of the Limbs Less << Phase 3 Completed - France ... More >> Institut Gustave-Roussy Villejuif, France, 94805 Less <<
NCT00006760 Lymphoma Phase 2 Completed - -
NCT00601718 Adult Nasal Type Extranodal NK... More >>/T-cell Lymphoma Anaplastic Large Cell Lymphoma Angioimmunoblastic T-cell Lymphoma Contiguous Stage II Mantle Cell Lymphoma Cutaneous B-cell Non-Hodgkin Lymphoma Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Nodal Marginal Zone B-cell Lymphoma Noncontiguous Stage II Mantle Cell Lymphoma Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Hodgkin Lymphoma Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent Small Lymphocytic Lymphoma Splenic Marginal Zone Lymphoma Stage I Cutaneous T-cell Non-Hodgkin Lymphoma Stage I Mantle Cell Lymphoma Stage I Mycosis Fungoides/Sezary Syndrome Stage II Cutaneous T-cell Non-Hodgkin Lymphoma Stage II Mycosis Fungoides/Sezary Syndrome Stage III Cutaneous T-cell Non-Hodgkin Lymphoma Stage III Mantle Cell Lymphoma Stage III Mycosis Fungoides/Sezary Syndrome Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma Stage IV Mantle Cell Lymphoma Stage IV Mycosis Fungoides/Sezary Syndrome Waldenstr?m Macroglobulinemia Less << Phase 1 Phase 2 Completed - United States, Washington ... More >> Puget Sound Oncology Consortium Seattle, Washington, United States, 98109 Less <<
NCT00004077 Testicular Germ Cell Tumor Phase 2 Completed - United Kingdom ... More >> Velindre Hospital Cardiff, Wales, United Kingdom, CF14 2TL Less <<
NCT00601718 - Completed - -
NCT03342300 Progression-free Survival ... More >> Overall Survival Toxicity Less << Phase 2 Phase 3 Recruiting December 30, 2019 China ... More >> Peking University People's Hospital Recruiting Beijing, China, 100044 Contact: Tingting Ren, Ph.D.    +86-13810095026    tumorcenter@163.com    Principal Investigator: Wei Guo, M.D. and Ph.D. Less <<
NCT02732015 Sarcoma Phase 2 Recruiting October 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT00001300 Sarcoma Phase 3 Completed - United States, Maryland ... More >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 Less <<
NCT00354107 - Terminated - -
NCT00003128 Sarcoma Phase 3 Completed - United States, Alabama ... More >> University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States, 35294-3300 United States, California Stanford Cancer Center at Stanford University Medical Center Stanford, California, United States, 94305-5216 United States, Illinois CCOP - Carle Cancer Center Urbana, Illinois, United States, 61801 United States, Indiana Indiana University Cancer Center Indianapolis, Indiana, United States, 46202-5289 CCOP - Northern Indiana CR Consortium South Bend, Indiana, United States, 46601 United States, Louisiana CCOP - Ochsner New Orleans, Louisiana, United States, 70121 United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231 United States, Massachusetts Tufts - New England Medical Center Boston, Massachusetts, United States, 02111 United States, Minnesota University of Minnesota Cancer Center Minneapolis, Minnesota, United States, 55455 United States, Nevada CCOP - Southern Nevada Cancer Research Foundation Las Vegas, Nevada, United States, 89106 United States, New Hampshire Norris Cotton Cancer Center at Dartmouth Medical School Lebanon, New Hampshire, United States, 03756-0002 United States, New York MBCCOP-Our Lady of Mercy Cancer Center Bronx, New York, United States, 10466 United States, Ohio Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 United States, Pennsylvania CCOP - Geisinger Clinic and Medical Center Danville, Pennsylvania, United States, 17822-2001 Abramson Cancer Center at University of Pennsylvania Medical Center Philadelphia, Pennsylvania, United States, 19104 Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111-2497 United States, Texas CCOP - Scott and White Hospital Temple, Texas, United States, 76508 Less <<
NCT00695032 Chemotherapeutic Agent Toxicit... More >>y Renal Toxicity Unspecified Adult Solid Tumor, Protocol Specific Less << Not Applicable Suspended - France ... More >> Institut Claudius Regaud Toulouse, France, 31052 Less <<
NCT00410488 Sarcoma Nause... More >>a Vomiting Less << Not Applicable Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01590732 Mycosis Fungoides ... More >> Recurrent Anaplastic Large Cell Lymphoma Recurrent Angioimmunoblastic T-Cell Lymphoma Recurrent Enteropathy-Associated T-Cell Lymphoma Recurrent Hepatosplenic T-Cell Lymphoma Recurrent Peripheral T-Cell Lymphoma, Not Otherwise Specified Refractory Anaplastic Large Cell Lymphoma Refractory Angioimmunoblastic T-Cell Lymphoma Refractory Enteropathy-Associated T-Cell Lymphoma Refractory Hepatosplenic T-Cell Lymphoma Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified Less << Phase 1 Completed - United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00354107 Anaplastic Large Cell Lymphoma... More >> Recurrent Childhood Anaplastic Large Cell Lymphoma Less << Phase 1 Phase 2 Terminated - United States, Pennsylvania ... More >> Children's Oncology Group Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00030784 Sarcoma Phase 1 Completed - Denmark ... More >> Aarhus University Hospital - Aarhus Sygehus - Norrebrogade Aarhus, Denmark, DK-8000 Germany Robert Roessle Comprehensive Cancer Center at University of Berlin - Charite Campus Buch Berlin, Germany, D-13122 Less <<
NCT00410488 - Completed - -
NCT00822848 Sarcoma Phase 1 Completed - United States, Oregon ... More >> OHSU Knight Cancer Institute Portland, Oregon, United States, 97239-3098 Less <<
NCT02544425 Extranodal NK-T-Cell Lymphoma Phase 2 Recruiting November 2019 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Seoul, Korea, Republic Of, Korea, Republic of, 135-710 Contact: WonSeog Kim, M.D, Ph. D    234106548 ext 82    wskimsmc@skku.edu    Contact: SeokJin Kim, M.D,Ph. D    234101766 ext 82    seokjin88.kim@samsung.com    Samsung Medical Center Recruiting Seoul, Korea, Republic of, 135-710 Contact: Wonseog Kim, M.D., Ph.D.    82-2-3410-6548    wonseog.kim@samsung.com    Contact: Seokjin Kim, M.D., Ph.D.       seokjin88.kim@samsung.com    Sub-Investigator: Seokjin Kim, M.D., Ph.D.          Principal Investigator: Wonseog Kim, M.D. Ph.D Less <<
NCT03212937 Peripheral T-cell Lymphoma Phase 1 Recruiting April 2019 Singapore ... More >> National Cancer Centre Singapore Recruiting Singapore, Singapore, 169610 Principal Investigator: Tiffany PL Tang Less <<
NCT01490060 Sarcoma Chemo... More >>therapy-induced Nausea and Vomiting Effects of Chemotherapy Adverse Effects of Medical Drugs Less << Not Applicable Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030-3722 Less <<
NCT01490060 - Completed - -
NCT01959698 CD20 Positive ... More >> Recurrent Diffuse Large B-Cell Lymphoma Refractory Diffuse Large B-Cell Lymphoma Stage I Diffuse Large B-Cell Lymphoma Stage II Diffuse Large B-Cell Lymphoma Stage III Diffuse Large B-Cell Lymphoma Stage IV Diffuse Large B-Cell Lymphoma Less << Phase 1 Phase 2 Recruiting July 15, 2023 United States, New York ... More >> Roswell Park Cancer Institute Recruiting Buffalo, New York, United States, 14263 Contact: Roswell Park    877-275-7724    ASKRPCI@RoswellPark.org    Principal Investigator: Francisco J. Hernandez-ILizaliturri Less <<
NCT00003198 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00788125 Brain and Central Nervous Syst... More >>em Tumors Childhood Germ Cell Tumor Extragonadal Germ Cell Tumor Kidney Cancer Liver Cancer Lymphoma Neuroblastoma Ovarian Cancer Sarcoma Testicular Germ Cell Tumor Unspecified Childhood Solid Tumor, Protocol Specific Less << Phase 1 Phase 2 Active, not recruiting September 2019 United States, California ... More >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010-3000 Less <<
NCT00003212 Sarcoma Phase 3 Completed - Belgium ... More >> Universitair Ziekenhuis Antwerpen Edegem, Belgium, B-2650 U.Z. Gasthuisberg Leuven, Belgium, B-3000 Denmark Aarhus Kommunehospital Aarhus, Denmark, DK-8000 Rigshospitalet Copenhagen, Denmark, 2100 France Centre Leon Berard Lyon, France, 69373 Institut Gustave Roussy Villejuif, France, F-94805 Germany Medizinische Hochschule Hannover Hannover, Germany, D-30625 Klinikum Grosshadern Munich, Germany, D-81377 Hungary National Institute of Oncology Budapest, Hungary, 1125 Netherlands Antoni van Leeuwenhoekhuis Amsterdam, Netherlands, 1066 CX Leiden University Medical Center Leiden, Netherlands, 2300 CA University Medical Center Nijmegen Nijmegen, Netherlands, NL-6252 HB Rotterdam Cancer Institute Rotterdam, Netherlands, 3075 EA Poland Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology Warsaw, Poland, 02-781 Slovakia National Cancer Institute - Bratislava Bratislava, Slovakia, 833 10 Spain Hospital Insular de Gran Canaria Las Palmas, Spain, G.C. United Kingdom St. James's Hospital Leeds, England, United Kingdom, LS9 7TF Royal Marsden NHS Trust London, England, United Kingdom, SW3 6JJ Middlesex Hospital- Meyerstein Institute London, England, United Kingdom, WIT 3AA Christie Hospital N.H.S. Trust Manchester, England, United Kingdom, M20 4BX Newcastle General Hospital Newcastle Upon Tyne, England, United Kingdom, NE4 6BE Nottingham City Hospital NHS Trust Nottingham, England, United Kingdom, NG5 1PB Weston Park Hospital Sheffield, England, United Kingdom, S1O 2SJ Less <<
NCT00127049 Germ Cell Tumor Phase 2 Unknown - France ... More >> Institut Gustave Roussy Recruiting Villejuif, France, 94805 Contact: Karim FIZAZI, Dr    33 1 42114559    fizazi@igr.fr Less <<
NCT03016871 CD (Cluster of Differentiation... More >>) 30-Positive Neoplastic Cells Present Recurrent Hodgkin Lymphoma Refractory Hodgkin Lymphoma TNFRSF8 Positive Less << Phase 2 Recruiting April 24, 2019 United States, California ... More >> City of Hope Medical Center Recruiting Duarte, California, United States, 91010 Contact: Robert W. Chen, MD    626-256-4673 ext 64762    rchen@coh.org    Principal Investigator: Robert W. Chen, MD          United States, Connecticut Yale University Not yet recruiting New Haven, Connecticut, United States, 06520 Contact: Gottfried von Keudell, MD    203-707-4257    gottfried.vonkeudell@yale.edu    Principal Investigator: Gottfried von Keudell, MD          United States, Texas M D Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030 Contact: Michelle A. Fanale, MD    713-792-2860    mfanale@mdanderson.org    Principal Investigator: Michelle A. Fanale, MD          United States, Washington Fred Hutchinson Cancer Research Center Not yet recruiting Seattle, Washington, United States, 98109 Contact: Ajay K. Gopal, MD    206-288-2035    agopal@u.washington.edu    Principal Investigator: Ajay K. Gopal, MD Less <<
NCT00381940 Adult Lymphocyte Depletion Hod... More >>gkin Lymphoma Adult Lymphocyte Predominant Hodgkin Lymphoma Adult Mixed Cellularity Hodgkin Lymphoma Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma Adult Nodular Sclerosis Hodgkin Lymphoma Childhood Lymphocyte Depletion Hodgkin Lymphoma Childhood Lymphocyte Predominant Hodgkin Lymphoma Childhood Mixed Cellularity Hodgkin Lymphoma Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma Childhood Nodular Sclerosis Hodgkin Lymphoma Recurrent Adult Hodgkin Lymphoma Recurrent/Refractory Childhood Hodgkin Lymphoma Stage I Adult Hodgkin Lymphoma Stage I Childhood Hodgkin Lymphoma Stage II Adult Hodgkin Lymphoma Stage II Childhood Hodgkin Lymphoma Stage III Adult Hodgkin Lymphoma Stage III Childhood Hodgkin Lymphoma Stage IV Adult Hodgkin Lymphoma Stage IV Childhood Hodgkin Lymphoma Less << Phase 2 Completed - United States, Pennsylvania ... More >> Children's Oncology Group Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00381940 - Completed - -
NCT02412267 Diffuse Large B-cell Lymphoma Phase 2 Completed - Singapore ... More >> National Cancer Centre Singapore, Singapore, 169610 Less <<
NCT00358540 Thrombocytopaenia Phase 1 Completed - United States, California ... More >> GSK Investigational Site Santa Monica, California, United States, 90403 United States, Florida GSK Investigational Site Miami, Florida, United States, 33136 GSK Investigational Site Tampa, Florida, United States, 33612 United States, Pennsylvania GSK Investigational Site Philadelphia, Pennsylvania, United States, 19106 United States, South Carolina GSK Investigational Site Greenville, South Carolina, United States, 29605 United States, Texas GSK Investigational Site Dallas, Texas, United States, 75246 GSK Investigational Site Houston, Texas, United States, 77030-4009 Less <<
NCT00484601 Refractory Nasopharyngeal Carc... More >>inoma Less << Phase 2 Terminated September 2010 Singapore ... More >> Johns Hopkins Singapore International Medical Center Singapore, Singapore, 308433 Less <<
NCT00189137 - Completed - -
NCT00283621 Sarcoma Not Applicable Completed - United States, Texas ... More >> UT MDAnderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00026078 Breast Cancer Phase 2 Unknown - Argentina ... More >> Grupo Oncologico Cooperativo del Sur Recruiting Bahia Blanca, Buenos Aires, Argentina, 8000 Contact: Juan Eduardo Perez, MD    54-291-452-5667    jperez@criba.edu.ar    Policlinica Privada Instituto De Medicina Nuclear Recruiting Bahia Blanca, Buenos Aires, Argentina, 8000 Contact: Alberto Omar Romero, MD    54-291-453-9848    gocsbhb@bvconline.com.ar    St. Joseph Medical Center Recruiting Gonnet, Buenos Aires, Argentina, 1987 MB Contact: Sergio Grasso, MD    54-221-4845088       Sanatorio Santa Rosa S.R.L. Recruiting Santa Rosa, La Pampa, Argentina, 6300 Contact: Eduardo Heriberto Ortiz, MD    54-2954-29-715       C.R I O. Recruiting Mar del Plata, Argentina, 7600 Contact: Ricardo L. Rodriguez, MD    54-223-479-3283    ricrodri@copetel.com.ar    Unidad Oncologica Del Neuquen Recruiting Neuquen, Argentina Contact: Bernardo A. Leone, MD    54-299-448-5247    bleone@satlink.com    Centro Oncologico Tres Arroyos Recruiting Tres Arroyos, Argentina, 7500 Contact: Maria Ester Dominguez, MD    0983-33450    medominquez@3net.com.ar    Mexico Centro Medico Nacional de Occidente Recruiting Guadalajara, Jalisco, Mexico, 4430 Contact: Gilberto Morgan Villela, MD    523-641-5081 Less <<
NCT01873326 Germ Cell Tumors Phase 2 Active, not recruiting June 2019 United States, California ... More >> University of Southern California Los Angeles, California, United States, 90033 Stanford University Medical Center Stanford, California, United States, 94305-5408 United States, Illinois University of Chicago Chicago, Illinois, United States United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, New Jersey Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States, 07748 United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan Kettering Westchester Harrison, New York, United States, 10604 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan Kettering Cancer Center at Mercy Medical Center Rockville Centre, New York, United States, 11570 United States, North Carolina University of North Carolina Chapel Hill, North Carolina, United States, 27514 United States, Pennsylvania University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT00423852 Brain and Central Nervous Syst... More >>em Tumors Extragonadal Germ Cell Tumor Ovarian Cancer Teratoma Testicular Germ Cell Tumor Less << Phase 1 Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00189137 Sarcoma, Soft Tissue Phase 2 Completed - United States, Michigan ... More >> University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109 Less <<
NCT00954174 Mixed Mesodermal (Mullerian) T... More >>umor Ovarian Carcinosarcoma Recurrent Fallopian Tube Carcinoma Recurrent Ovarian Carcinoma Recurrent Primary Peritoneal Carcinoma Stage I Ovarian Cancer Stage IA Fallopian Tube Cancer Stage IA Ovarian Cancer Stage IA Uterine Sarcoma AJCC v7 Stage IB Fallopian Tube Cancer Stage IB Ovarian Cancer Stage IB Uterine Sarcoma AJCC v7 Stage IC Fallopian Tube Cancer Stage IC Ovarian Cancer Stage IC Uterine Sarcoma AJCC v7 Stage II Ovarian Cancer Stage IIA Fallopian Tube Cancer Stage IIA Ovarian Cancer Stage IIA Uterine Sarcoma AJCC v7 Stage IIB Fallopian Tube Cancer Stage IIB Ovarian Cancer Stage IIB Uterine Sarcoma AJCC v7 Stage IIC Fallopian Tube Cancer Stage IIC Ovarian Cancer Stage IIIA Fallopian Tube Cancer Stage IIIA Ovarian Cancer Stage IIIA Primary Peritoneal Cancer Stage IIIA Uterine Sarcoma AJCC v7 Stage IIIB Fallopian Tube Cancer Stage IIIB Ovarian Cancer Stage IIIB Primary Peritoneal Cancer Stage IIIB Uterine Sarcoma AJCC v7 Stage IIIC Fallopian Tube Cancer Stage IIIC Ovarian Cancer Stage IIIC Primary Peritoneal Cancer Stage IIIC Uterine Sarcoma AJCC v7 Stage IV Fallopian Tube Cancer Stage IV Ovarian Cancer Stage IV Primary Peritoneal Cancer Stage IVA Uterine Sarcoma AJCC v7 Stage IVB Uterine Sarcoma AJCC v7 Uterine Carcinosarcoma Less << Phase 3 Active, not recruiting - -
NCT00836173 Diffuse Large B-cell Lymphoma Phase 2 Withdrawn(Gallium is no longer... More >> available for the conduct of this study.) Less << - United States, Illinois ... More >> Loyola Univeristy Medical Center, Cardinal Bernardin Cancer Center Maywood, Illinois, United States, 60153 Less <<
NCT02718482 OSTEOSARCOMA Phase 2 Recruiting April 2025 Italy ... More >> Fondazione del Piemonte per l'Oncologia IRCC Candiolo Recruiting Candiolo, Torino, Italy, 10060 Contact: Massimo Aglietta, MD    0039-011-9933628    massimo.aglietta@ircc.it    Contact: Giovanni Grignani, MD    0039-011-9933623    giovanni.grignani@ircc.it    Principal Investigator: Massimo Aglietta, MD          Sub-Investigator: Giovanni Grignani, MD          Sub-Investigator: Lorenzo D'Ambrosio, MD          Ospedale Gradenigo Not yet recruiting Torino, TO, Italy, 10153 Contact: Alessandro Comandone, MD    +390118151271    alessandro.comandone@gradenigo.it    Principal Investigator: Alessandro Comandone, MD          Istituti Ortopedici Rizzoli - Unit of Chemotherapy of Muscoloskeletal Tumors Recruiting Bologna, Italy, 40136 Contact: Stefano Ferrari, MD    +390516366199 ext 199    stefano.ferrari@ior.it    Principal Investigator: Stefano Ferrari, MD          A.O. Universitaria Meyer Recruiting Firenze, Italy, 50139 Contact: Angela Tamburini, MD    +3905556 ext 621    a.tamburini@meyer.it    Principal Investigator: Angela Tamburini, MD          Istituto Giannina Gaslini Not yet recruiting Genova, Italy Contact: Alberto Garaventa, MD    +390105636 ext 694    CarlaManzitti@ospedale-gaslini.ge.it    Principal Investigator: Alberto Garaventa, MD          FONDAZIONE IRCCS Istituto Nazionale dei Tumori Recruiting Milano, Italy Contact: Rossella Bertulli, MD    +390223903 ext 287    rossella.bertulli@istitutotumori.mi.it    Principal Investigator: Rossella Bertulli, MD          Principal Investigator: Cristina Meazza, MD          Università seconda di Napoli Recruiting Napoli, Italy, 80100 Contact: Fiorina Casale, Prof.    +390815665 ext 412    fiorina.casale@unina2.it    Azienda Ospedaliera di Padova Recruiting Padova, Italy Contact: Gianni Bisogno, MD    +390498211 ext 475    gianni.bisogno@unipd.it    Principal Investigator: Gianni Bisogno, MD          Istituto Regina Elena - IFO Recruiting Rome, Italy, 00100 Contact: Virginia Ferraresi, MD    +39065266919    ferraresi@ifo.it    Ospedale Infantile Regina Margherita - Unit of Paediatric Oncoematology Recruiting Torino, Italy, 10126 Contact: Franca Fagioli, MD    +39.011.3135 ext 230    franca.fagioli@unito.it    Principal Investigator: Franca Fagioli, MD Less <<
NCT00423852 - Completed - -
NCT01300793 Non-Hodgkin's Lymphoma ... More >> B-cell Lymphoma Less << Phase 1 Terminated(closed for low accr... More >>ual and no data is available.) Less << - United States, California ... More >> Unviersity of California Medical Center San Francisco, California, United States, 94143 Less <<
NCT00541840 Soft Tissue Sarcoma Phase 1 Phase 2 Unknown April 2010 Spain ... More >> Grupo Geis Recruiting Madrid, Spain, 28001 Contact: Xavier Garcia del Muro, MD    915775281    info@grupogeis.org    Principal Investigator: Xavier Garcia del Muro, MD Less <<
NCT00515138 Lymphoma, B-Cell Early Phase 1 Terminated(Investigator left i... More >>nstitution. 7 patients accrued and there is insufficient data to analyze.) Less << - United States, California ... More >> University of California San Francisco San Francisco, California, United States, 94143 Less <<
NCT03283696 Soft Tissue Sarcoma Phase 1 Recruiting November 8, 2019 United States, Florida ... More >> University of Miami School of Medicine Recruiting Miami, Florida, United States, 33136 Contact    305-243-6102       Principal Investigator: Jonathan C Trent          United States, Texas University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact    713-792-3626       Principal Investigator: Neeta Somaiah          Germany Universitätsklinikum Essen Recruiting Essen, Nordrhein-Westfalen, Germany, 45122 Contact    4920172385558       Principal Investigator: Sebastian Bauer          HELIOS Klinikum Berlin-Buch Recruiting Berlin, Germany, 13125 Contact    4930940154801       Principal Investigator: Peter Reichardt          Italy Istituto Nazionale dei Tumori Recruiting Milano, Lombardie, Italy, 20133 Contact    390223902182       Principal Investigator: Silvia Stacchiotti          Università degli Studi di Catania - Azienda Policlinico Recruiting Catania, Italy, 95123 Contact    390953781496       Principal Investigator: Hector Soto Parra Less <<
NCT00231842 Uterine Cancer Phase 2 Completed - United States, New York ... More >> Montefiore Medical Center Bronx, New York, United States, 10461 Less <<
NCT02137096 - Completed - United States, Florida ... More >> UF Health Shands Hospital Gainesville, Florida, United States, 32610 Less <<
NCT01703754 Breast Cancer Nos Metastatic R... More >>ecurrent Less << Phase 2 Completed - United States, Florida ... More >> Baptist Cancer Institute Jacksonville, Florida, United States, 32207 United States, Michigan Henry Ford Health System Detroit, Michigan, United States, 48202 United States, Montana Billings Clinic Billings, Montana, United States, 59101 United States, Ohio Signal Point Clinical Research Center Middletown, Ohio, United States, 45042 United States, South Carolina Greenville Hospital System Greenville, South Carolina, United States, 29605 United States, Tennessee The Jones Clinic, PC Germantown, Tennessee, United States, 38138 United States, Texas Mary Crowley Medical Research Center Dallas, Texas, United States, 75201 United States, Washington Evergreen Hematology & Oncology Spokane, Washington, United States, 99218 Less <<
NCT00289809 Sarcoma, Soft Tissue Phase 1 Phase 2 Completed - Italy ... More >> Istituto Clinico Humanitas Rozzano, Milan, Italy, 20089 Less <<
NCT01752517 - Unknown December 2015 China, Beijing ... More >> Department of Respiratory Medicine, Peking Union Medical College Hospital Recruiting Beijing, Beijing, China, 100730 Contact: Mengzhao Wang, MD    010-69155039 ext +86    mengzhaowang@sina.com    Contact: Jing Zhao, MD    010-69158206 ext +86    pumchzj@sina.com    Sub-Investigator: Wei Zhong, MD          Sub-Investigator: Jinmei Luo, MD Less <<
NCT01555710 Extensive-Stage Small Cell Lun... More >>g Cancer Less << Phase 3 Unknown June 2015 -
NCT02235701 Metastatic, Locally Advanced, ... More >>or Unresectable Soft Tissue Sarcoma Less << Phase 1 Phase 2 Unknown December 2018 United States, California ... More >> Sarcoma Oncology Center Recruiting Santa Monica, California, United States, 90403 Contact: Victoria Chua    310-552-9999    vchua@sarcomaoncology.com    Principal Investigator: Sant Chawla, M.D. Less <<
NCT00967291 Pancreatic Cancer Phase 2 Terminated(lack of activity an... More >>d G3-4 toxicity at interim analysis) Less << - Italy ... More >> Istituto Scientifico H. San Raffaele Milan, Italy, 20132 Less <<
NCT00502892 Solid Tumors Phase 1 Completed - United States, Texas ... More >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00003292 Chondrosarcoma ... More >> Adult Fibrosarcoma Adult Leiomyosarcoma Adult Rhabdomyosarcoma Adult Malignant Meningioma Adult Brain Malignant Hemangiopericytoma Less << Phase 2 Terminated(lack of accrual) - -
NCT00086970 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Terminated(Administratively co... More >>mplete.) Less << - United States, Illinois ... More >> University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637-1470 Less <<
NCT03383406 Diffuse Large B Cell Lymphoma Phase 2 Enrolling by invitation December 31, 2025 -
NCT01784107 Small Cell Lung Cancer Phase 1 Phase 2 Unknown - Korea, Republic of ... More >> Gachon University Gil Medical Center Recruiting Incheon, Korea, Republic of Contact: Hee Kyung Ahn    +82-32-460-3229    hkahn@gilhospital.com Less <<
NCT02812654 Sarcoma, Soft Tissue Phase 2 Recruiting March 2019 Brazil ... More >> A.C.Camargo Cancer Center Recruiting São Paulo, Sao Paulo, Brazil, CEP 01509 - 010 Contact: Bruna C Kupper, Nurse    55-11-21895000 ext 2946    bruna.sousa@accamargo.org.br Less <<
NCT00607711 Advanced Cancer Phase 1 Suspended(IND was withdrawn) November 2009 -
NCT02227199 Recurrent Adult Hodgkin Lympho... More >>ma Refractory Hodgkin Lymphoma TNFRSF8 Positive Less << Phase 1 Phase 2 Recruiting - United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Ajay K. Gopal    206-606-2037    agopal@u.washington.edu    Principal Investigator: Ajay K. Gopal Less <<
NCT03514381 Soft Tissue Sarcoma Phase 4 Recruiting July 2020 France ... More >> Institut Bergonie Not yet recruiting Bordeaux, France, 33076 Contact: Maud TOULMONDE, MD    05 56 33 32 78    m.toulmonde@bordeaux.unicancer.fr    Institut Regional Du Cancer de Montpellier (Icm) Not yet recruiting Montpellier, France, 34298 Contact: Nelly FIRMIN, MD    04 67 61 45 65    nelly.firmin@icm.unicancer.fr    Institut Universitaire Du Cancer de Toulouse - Oncopole Recruiting Toulouse, France, 31059 Contact: Thibaud VALENTIN, MD    05 31 15 51 51    valentin.thibaud@iuct-oncopole.fr Less <<
NCT01168791 Soft Tissue Sarcoma Phase 3 Completed - -
NCT01102608 Soft Tissue Sarcoma Phase 2 Completed - Spain ... More >> Grupo Espanol de Investigación en Sarcomas Barcelona, España, Spain, 08006 Less <<
NCT01749072 Non-small Cell Lung Cancer ... More >> Effects of Chemotherapy Less << Phase 2 Unknown December 2017 China, Beijing ... More >> Department of Respiratory Medicine, Peking Union Medical College Hospital Recruiting Beijing, Beijing, China, 100730 Contact: Mengzhao Wang, MD    010-69155039 ext +86    mengzhaowang@sina.com    Contact: Jing Zhao, MD    010-69158206 ext +86    pumchzj@sina.com    Sub-Investigator: Wei Zhong, MD          Sub-Investigator: Jinmei Luo, MD Less <<
NCT01872416 Small Cell Lung Cancer Phase 2 Unknown May 2015 China, Guangdong ... More >> he First Affiliated Hospital of Guangzhou Medical College Recruiting Guangzhou, Guangdong, China, 510120 Contact: Jianxing He, MD    +86-20-83062808    hejx@vip.163.com    Contact: Yalei Zhang, Master    +86-20-83062821    yayazhang2004@163.com Less <<
NCT00718484 Soft Tissue Sarcoma Phase 2 Unknown April 2014 -
NCT00880542 Sarcoma Phase 2 Terminated(The study lost fund... More >>ing.) Less << - United States, California ... More >> Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States, 90095-1781 Less <<
NCT02808247 Sarcoma, Soft Tissue Phase 2 Recruiting January 2022 Belgium ... More >> Hopitaux Universitaires Bordet-Erasme - Institut Jules Bordet Recruiting Brussels, Belgium, 1000 Contact: Gil Thierry    +32 25413188    thierry.gil@bordet.be    Cliniques Universitaires Saint-Luc (121) Recruiting Brussels, Belgium Contact: Filomena Mazzeo       Filomena.Mazzeo@uclouvain.be    U.Z. Leuven - Campus Gasthuisberg (147) Recruiting Leuven, Belgium Contact: Patrick Schöffski       patrick.schoffski@uzleuven.be    France Institut Bergonie Recruiting Bordeaux, France, 33076 Contact: Antoine Italiano       a.italiano@bordeaux.unicancer.fr    Centre Leon Berard (227) Recruiting Lyon, France Contact: Jean-Yves Blay       jean-yves.blay@lyon.unicancer.fr    Gustave Roussy (225) Recruiting Villejuif, France Contact: Olivier Mir       olivier.mir@gustaveroussy.fr    Lithuania Vilnius University Hospital Santariskiu Santaros Clinics Klinikos (9453) Recruiting Vilnius, Lithuania, 08661 Netherlands The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis (301) Recruiting Amsterdam, Netherlands, 1066 Leiden University Medical Centre (310) Recruiting Leiden, Netherlands, 2300 Poland Maria Sklodowska-Curie Memorial Cancer Centre Recruiting Warsaw, Poland, 02 781 Contact: Piotr Rutkowski       rutkowskip@coi.waw.pl    Spain Institut Catala d'Oncologia - ICO Badalona - Hospital Germans Trias i Pujol (Institut Catala D'Oncologia) Recruiting Barcelona, Spain, 08916 Contact: Anna Estival       estivalanna@gmail.com    Hospital Universitario San Carlos (366) Recruiting Madrid, Spain, 28040 United Kingdom Royal Marsden Hospital - Chelsea, London (613) Recruiting London, United Kingdom, SW3 6JJ Less <<
NCT01808534 Adult Central Nervous System G... More >>erm Cell Tumor Adult Teratoma Malignant Extragonadal Germ Cell Tumor Malignant Extragonadal Non-Seminomatous Germ Cell Tumor Extragonadal Seminoma Recurrent Malignant Testicular Germ Cell Tumor Recurrent Ovarian Germ Cell Tumor Stage IV Extragonadal Non-Seminomatous Germ Cell Tumor Stage IV Extragonadal Seminoma Stage IV Ovarian Germ Cell Tumor Less << Phase 2 Terminated(Due to Low Accrual) - United States, Indiana ... More >> Indiana University Cancer Center Indianapolis, Indiana, United States, 46202 United States, Pennsylvania Abramson Cancer Center of The University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 United States, Washington Virginia Mason Medical Center Seattle, Washington, United States, 98101 Less <<
NCT01808534 - Terminated(Due to Low Accrual) - -
NCT01242072 Malignancy Ca... More >>ncer Non Small Cell Lung Cancer Small Cell Lung Cancer Testicular Cancer Thymoma Ovarian Cancer Osteosarcoma Less << Phase 1 Unknown December 2012 United States, Indiana ... More >> Indiana University Simon Cancer Center Indianapolis, Indiana, United States, 46202 Horizon Oncology Research Lafayette, Indiana, United States, 47905 Medical Consultants, PC Muncie, Indiana, United States, 47303 United States, Missouri Washington University St. Louis, Missouri, United States, 63110 Less <<
NCT01340547 Advanced Solid Tumors Phase 1 Unknown September 2013 United States, Texas ... More >> Dallas, Texas, United States, 75230 Houston, Texas, United States, 77030 San Antonio, Texas, United States, 78229 Less <<
NCT00880542 - Terminated(The study lost fund... More >>ing.) Less << - -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.52mL

0.90mL

0.45mL

22.62mL

4.52mL

2.26mL

45.24mL

9.05mL

4.52mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories